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CHAPTER 1:  Chronic infection by Leishmania amazonensis mediated through 
MAPK ERK mechanisms 
A paper submitted for publication in Immunologic Research 
Pedro A. Martinez and Christine A. Petersen* 
 
 
Abstract 
 Leishmania amazonensis is an intracellular protozoan parasite responsible for 
chronic cutaneous leishmaniasis (CL).  CL is a neglected tropical disease responsible 
for infecting millions of people worldwide.  L. amazonensis promotes alteration of 
various signaling pathways that are essential for host cell survival. Specifically, through 
parasite-mediated phosphorylation of extracellular signal regulated kinase (ERK), L. 
amazonensis inhibits cell-mediated parasite killing and promotes its own survival by co-
opting multiple host cell functions.  In this review we highlight Leishmania-host cell 
signaling alterations focusing on those specific to 1) motor proteins, 2) prevention of 
NADPH subunit phosphorylation impairing reactive oxygen species production (ROS), 
and 3) localized endosomal signaling to up-regulate ERK phosphorylation.  This review 
will focus upon mechanisms and possible explanations as to how Leishmania spp. 
evades the various layers of defense employed by the host immune response.   
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Introduction 
Leishmania infection importance: Epidemiology 
 Leishmania spp. are obligate intracellular parasites in the family 
Trypanosomatidae.  They are the causative agents of the spectral disease, 
leishmaniasis.  Leishmaniases are neglected tropical diseases transmitted by infected 
sand flies.  Sand flies belong to either Lutzomyia (New World) or Phlebotomus (Old 
World) geneses.  There are roughly 30 documented species of Leishmania, with 20 of 
these able to cause disease in humans.  Currently, approximately 12 million people are 
infected worldwide, which makes Leishmaniasis a global issue, affecting individuals in 
98 countries. The disease is responsible for roughly 70,000 deaths per year [1], most of 
these attributed to the visceralizing form of the disease. In the few past years, we have 
seen a rise in canine visceral leishmaniasis (VL) [2] in the US, as well as in Europe.  
This places leishmaniasis within the coasts of the most industrialized nations in the 
world and is no longer a solely a problem in third world countries. While we currently do 
not know of any reported VL cases transmitted from a canine to a human in the US, 
because of the proximity of infected canines, with immunocompromised and other 
individuals, the possibility is always there [3]. 
 Cutaneous leishmaniasis (CL) is defined as disease caused by Leishmania spp. 
and leads to an ulcerative skin lesion(s).  However, different strains of the same species 
of a parasite can have very different clinical outcomes. Leishmania tropica and 
Leishmania amazonensis for example typically cause CL, yet they are also capable of 
causing visceral disease in some cases. Meanwhile, L. infantum infection, which can 
lead to fatal VL, can also cause CL without any type of parasite dissemination to the 
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spleen or liver. Many of these outcomes are due to specific parasite characteristics that 
vary by species; however, disease outcome also heavily depends on the response of 
the host immune system. 
 The main sand fly vector of L. amazonensis is Lutzomyia flaviscutellata [4]. There 
are hundreds of sand fly species, but only 30 of them are documented to transmit 
Leishmania spp.  CL ulcers tend to become necrotic in the center and are elevated at 
the sides [4]. Lymphadenopathy, or enlarged lymph nodes, has been reported to 
precede ulcer formation [5].   Cutaneous lesions measure an average of 3cm [4] 
depending greatly on the host immune response.  While individuals with a robust 
immune system tend to clear the skin lesion with limited scarring, the parasite is able to 
reside in the host for life, persisting latently within fibroblasts [6]. Individuals with co-
infections, or a weakened immune system, do not clear the parasite well.  
  Leishmania, beyond causing disfiguring ulcers, also causes irreparable 
psychological damage in afflicted individuals in areas that tend to be poverty ridden.  In 
addition to causing disease, leishmaniasis is also a major social stigma.  This takes 
upon an elevated significance in poor areas, because these individuals usually do not 
have access to proper healthcare. Therefore, they are more prone to secondary 
infections and more severe outcomes of CL.  
 To date, no vaccine currently exists for humans, and while various treatments are 
available with a plethora of results, they all can be hepatotoxic.  These medications also 
are expensive for the individuals that need them, creating a unique situation in which 
the medication is theoretically available but, because of economic reasons, is out of 
range for most infected individuals.  It is troublesome to know that the ‘discounted’ 
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World Health Organization (WHO) price of Miltefosine is $84 per individual that weighs 
more than 25 pounds [7], and the average daily wage in the endemic region of India is 
$1. Cases have been reported of drug resistance in individuals that live in a constant 
state of Leishmania spp. exposure.  Due to this situation, it is critical to identify novel 
targets for leishmaniasis treatments.  
Leishmania amazonensis 
 CL is caused by various Leishmania spp., most of them found in the New World, 
including but not limited to Leishmania braziliensis, Leishmania mexicana, Leishmania 
peruviana, and L. amazonensis.  Leishmania major, which is primarily located in the Old 
World, also causes CL and causes a more-readily healed version of the disease.  The 
Leishmania spp. lifecycle consists of two predominant forms (Figure 1). Leishmania can 
be infectious during the amastigote life stage, however, it is transmitted via a sand fly in 
the metacyclic promastigote stage, when it is most infectious.   Upon entering the host, 
parasites will inhabit the very cells that are sent to remove them; macrophages (Figure 
2).  Once within macrophages or other phagocytic cells, the promastigotes transform 
into the aflagellate amastigote state. Like many pathogens, Leishmania spp. are often 
first met by neutrophils but can later infect a variety of cell types, amongst these 
dendritic cells, fibroblasts and primarily macrophages [8]. 
 L. amazonensis is unique among Leishmania spp., due to its ability to activate 
MAPK extracellular signal regulated kinase (ERK1/2), which promotes chronic L. 
amazonensis infection.  Most members of the L. mexicana complex, of which L. 
amazonensis is a part, cause chronic disease, unlike L. major [9]. L. amazonensis is 
able to subvert the immune response by the host.  Specifically, ERK1/2 is manipulated 
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by the parasite ERK1/2 activation through phosphorylation to cause a variety of 
downstream functions that ultimately promote its own survival and persistence.  
Leishmania spp. surface coat/virulence factors 
 Leishmaniasis outcome depends as much on the host immune response as on 
the virulence of the infecting parasite. Leishmania parasites are covered by a thick 
glycocalyx, which includes lipophosphoglycan (LPG), gp63 [10], proteophosphoglycans 
(PPGs) and glycoinositol phospholipids (GIPLs). LPG is the main component of the 
glycocalyx, and the composition of the glycocalyx has been directly correlated to 
parasite virulence [11].  
Inoculation into the host 
 Once Leishmania spp. are introduced as promastigotes into naïve hosts via sand 
flies, resident neutrophils, dendritic cells, and macrophages rapidly engulf them.  While 
the parasite will mostly inhabit macrophages as amastigotes, it is appreciated that 
neutrophils may be the first cells to respond to the site of feeding and infection [12].  
Neutrophils have a very short life span and undergo apoptosis at the end of it; 6-10 
hours is their half-life in circulation [13].  Their role in protection against Leishmania spp. 
is under debate.  Most of the literature indicated that neutrophils were not very useful in 
the immune response to Leishmania.  Neutrophils may be more detrimental than 
beneficial, as they have been proposed to establishing infection as a “Trojan Horse”.  
Neutrophils were shown to ingest Leishmania parasites, delaying neutrophil apoptosis 
[14].  During this hiatus in apoptosis, which lasted roughly two days, macrophage 
migration to the infection site was enhanced via neutrophil secretion of chemokine MIP-
1β, a macrophage chemo-attractant.  Upon macrophage arrival, the infected now 
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apoptotic neutrophils were engulfed by macrophages based on anti-inflammatory 
signaling which promoted a dampened response to infection by the parasite. As a 
result, Leishmania was able to silently enter into their definitive host and establish 
infection [12].  
Parasite uptake and entry 
 Parasite entry by phagocytosis can occur via mannose receptors, pattern 
recognition receptors, or endocytosis. The parasite then eventually resides within the 
acidic environment of the late endosome/parasitophorous vacuole. The main receptors 
involved in parasite uptake and internalization include mannose receptors (MR), first 
complement receptor (CR1), third complement receptor (CR3), Fcγ-Receptors (primarily 
FcγRII-B2) and FnRs (Fibronectin receptors)[15, 16].  Depending on the receptor used, 
entry into the cell could be advantageous to the parasite.  For example, IL-10 production 
as a result of FcγR ligation with bone marrow derived macrophages (BMM), enhanced 
survival of the parasite [17].  Promastigotes expressed increased levels of gp63, able to 
convert C3 into C3b, which is a ligand for CR1 found on macrophages, neutrophils and 
DCs [15].  CR1, through the use of Factor I, cleaved C3b into iC3b, which bound to 
phagocyte CR3 and facilitated parasite entrance [15].  MRs are a C-type lectin that 
binds to mannose with high affinity.  However, its role in the immune response to 
Leishmania is two-sided. Studies have shown that MR ligation was able to induce 
inflammatory cytokines, something the parasite would try to prevent for survival.  MR 
engagement has been shown to induce anti-inflammatory responses [15].   Because 
many of these receptors are known to act synergistically, it is possible that the 
responses seen were not due solely to MR engagement but rather are the product of 
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another receptor in concert with MR.  Leishmania surface molecules vary widely; 
therefore it is very hard to elucidate specific or predominant molecules that interact with 
specific host molecules. Surface molecules highly upregulated on the metacyclic form of 
the parasite were not present on the aflagellate amastigote form of the parasite [18].  
Myeloid phagocytic host cells also vary greatly in their specific surface receptor 
composition. As reviewed by Ueno [15], different macrophages and species of 
Leishmania vary in their molecular surface composition, which leads to unique cell to 
cell host-parasite receptor interactions. 
Phagocytosis and parasitophorous vacuole formation 
 Adding to the differences in parasite recognition are also different uptake 
mechanisms, depending on the species of the parasite. L. amazonensis as well as L. 
donovani encounter and contact bone marrow macrophages anterior end or “flagella-
first”, only to then orient themselves in the opposite way so that their posterior end was 
then phagocytized [19].  The parasite is then enclosed within a parasitophorous vacuole 
(PV).  PVs are compartments that are found within the host cell, where the parasite will 
remain during infection, multiplying and differentiating [20].  The PV initially consists of 
plasma membrane; however, after various fusion and fission events with other vesicles 
including early and late endosomes, secondary lysosomes, and ER [20], it will 
eventually have characteristics of a spectrum of compartments. Fission events include 
L. major PVs, which will undergo this process as parasites divide [20].  The resultant PV 
has an acidic pH much like a phagolysosome [21-24]. This makes the PV unique and 
different from a lysosome or endosome, as the PV is also a constantly changing 
membrane in respect to composition as it fuses with these various compartments, 
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including parasite exosomes [21, 25, 26].  PV established by different Leishmania spp. 
range from small (L. major) and harboring anywhere from 1-2 amastigotes to hosting 
multiple amastigotes in much larger vacuoles, as in the case with L. amazonensis [20].   
The biogenesis of PV [20] involves acquiring markers present in late endosomes of the 
host, including lysosome-associated membrane proteins (LAMP), MHC II molecules and 
Rabs [27].  Rab7 was associated with the PV, however, it has also been reported on 
early endosomes [28], perhaps during the transition of Rab5 being replaced by Rab7.  
Once these markers are all assembled together, the PV is now mature, which permits 
further replication and survival of L. amazonensis amastigotes. 
Immune response to Leishmania spp. 
 Upon infection with Leishmania spp., lesion resolution depends mainly on 
whether a TH1 or non-TH1 response is elicited.  T0, or naïve CD4+ T-cells are able to 
differentiate into different lineages/subsets depending on the local cytokine milieu they 
receive.  These subsets include the helper T-cell subsets: TH1, TH2, TH9, TH17, as well 
as regulatory T-cells (Treg) [29]. 
TH1 subset 
 T-bet is the transcription factor responsible for a TH1 response through direct 
induction of IFN-γ production.  T-bet expression in dendritic cells (DCs) is essential for 
TH1 differentiation in naïve CD4+ T cells, the IFN-γ produced by DCs will then prime 
CD4 T-cells to promote TH1 differentiation [30].  A commitment towards a TH1 lineage is 
induced primarily through the inflammatory cytokine IL-12.  IL-12 is produced mainly by 
antigen presenting cells (APCs) and has two subunits, p35 and p40. While p35 is 
constitutively expressed in a variety of cells, p40 is unique as it is secreted only by cells 
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that are producing active IL-12 [31].  In macrophages, NF-κΒ is responsible for induction 
of the p40 gene, as studies have shown that c-Rel is required for p40 induction [32].  
IFN-γ is able to augment the production of IL-12 (in a positive feedback) while IL-10, an 
anti-inflammatory cytokine, is known to downregulate IL-12 production.  The role of IL-
12, similar to many other cytokines and immune responses, can be contradictory 
dependent on Leishmania species.  It is mostly accepted that a robust cell-mediated 
TH1 response is needed to successfully resolve a Leishmania infection, and that a lack 
thereof is associated with susceptibility.  Buxbaum et al.[33] showed that BL/6 mice are 
able to clear Leishmania infection without the need for IL-12. On the other hand, Ramer-
Tait et al. [34] showed that exogenous IL-12 treatment was not sufficient to induce/skew 
the response in C3H mice infected with L. amazonensis towards a TH1 response.  
Therefore, while the role of IL-12 in a TH1 response is well established, its sufficiency for 
Leishmania recovery has to be taken on a species-dependent basis.  
 IFN-γ is classically produced by TH1-polarized T-cells.  A recent report 
suggested that a subpopulation of CD11ahiFcγRIIIhiCD19+ B cells were also capable of 
producing IFN-γ at high levels [35].   While much of the literature has not found B cells 
to play a significant role in a healing response to CL, this recent finding regarding B cell 
production of IFN-γ might support previous data that implicates B cells in healing.  L. 
amazonensis does not heal in infected C3H/FeJ and BL/6 mice.  However, mice were 
able to heal when co-infected with L. major in C3H/FeJ.  While this was muted in 
C57BL/6 mice, it was attributed to a poor B cell response [36].  Gibson-Corley et al. [37] 
found that B cells had an important role eliminating L. amazonensis from C3H mice. 
While the mechanisms and the level of aid by B cells against Leishmania spp. infection 
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are not completely understood, B cells may play a role in healing an otherwise non-
healing L. amazonensis infection.  
 Because a TH1 type response will produce pro-inflammatory cytokines, such 
as IFN-γ, and IL-12, the body regulates and counters the inflammatory response with 
cytokines such as IL-4, IL-5, IL-13, and IL-10 to prevent damage to the host [38]. Upon 
infection with Leishmania spp., a TH1 response will typically result in parasite clearance 
due to IFN-γ and other signal-mediated up-regulation of pro-inflammatory cytokines that 
trigger pathways that lead to activated macrophages via IFN-γ.  These active 
macrophages can subsequently kill Leishmania via signaling pathways that produce 
reactive oxygen species (ROS) or through the inducible nitric oxide synthase (iNOS) 
pathway. 
MAPK Pathway 
 In 1994, the mitogen activated protein kinases (MAPK); a family of protein 
(Ser/Thr) kinases [39] was discovered. While much has been learned about this family 
of kinases since then, we still lack knowledge regarding specific substrates targeted by 
MAPKs.  Kinases add inorganic phosphate groups to targeted motifs on other protein 
substrates.  These phosphate groups are donated from adenosine triphosphate (ATP) 
and are usually added at the OH group of Serine (Ser), Threonine (Thr) or Tyrosine 
(Tyr) sites. However, they can be added to additional sites such as histidine.  Kinases 
are broadly specific, which is essential as it allows them to regulate cell function from 
one cell signal by acting on one, two, or all three sites of a substrate.  
 Evolutionary conservation across MAPK may be explained by the high degree of 
involvement in almost every aspect of cellular function and regulation [40].  Once 
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MAPKs are activated, resultant pathways will provide cellular outcomes such as control 
of the cell cycle, apoptosis, differentiation and proliferation [41].  There are three 
conventional MAPK core pathways, ERK1/2, JNK, and p38, that are the best studied 
and understood, however some included ERK5 amongst this group (Figure 3).  Other 
groups of MAPK exist but do not fit the standard definition of the aforementioned 
MAPKs, such as ERK3/4, ERK7 and nemo-like-kinase (NLK), because they do not 
share the same phosphorylation sites of conventional MAPK. The MAPK pathway is a 
three-tiered module system [42] of signaling molecules, where threonine and tyrosine 
make up the activation loop of the kinases to be phosphorylated prior to activation [43]. 
MAPKs are conformed of the following three conserved and sequentially acting kinases: 
MAPK, MAPK Kinase (MAPKK), and a MAPKK kinase (MAPKKK) [44].  Within this 
tiered system, the MAPKs undergo activation when a phosphate group is added to a 
conserved Thr-x-Tyr motif which is located on the VIII activation loop of the kinase 
subdomain [40].  
 MAPK phosphorylation occurs through members that belong to the double 
specificity MAPKK (MEK1/2/MAP2Ks).  MEK1/2, much like the MAPKs, is also activated 
via phosphorylation at their own serine and/or threonine sites, which is also located in 
the kinase subdomain VIII. MEK1/2 is phosphorylated by upstream components known 
as MAPKKK (MAP3Ks/MKKs) [41, 45].   Because there are many components that are 
part of the MAPK pathway, it is possible for them to be involved in multiple cascades, 
however the specificity in signaling that is characteristic of this pathway is due to 
scaffolding proteins.  These pathways are activated via either inflammatory signals or 
stress. To function, agonists will engage the MAPKKKs through either Ras/Rho which 
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are small GTP-binding proteins. MAPKKK activation leads to activation of MAPKK, and 
further on to activation of MAPK by dual phosphorylation on Thr and Tyr residues.  The 
ERK1/2 pathway functions via activation of Raf (MAPKKK), which through 
phosphorylation activates MEK1/2 (MAPKK), which will then phosphorylate and activate 
ERK1/2 (MAPK) (Figure 3).  ERK1/2 substrates have been shown to be located both in 
the cytoplasm and nucleus post ERK1/2 phosphorylation.  ERK1/2 nucleus 
translocation is needed as a requirement for important biologically relevant responses 
[46]. While this is how the pathways are usually activated, ERKs have been shown to 
not necessarily need Ras to become activated and, in fact, can be activated by 
pathogen associated molecular patterns (PAMPs), danger associated molecular 
patterns (DAMPs) and a range of pro-inflammatory stimuli. 
 All MAPKs will go on to further activate key substrates, most which are unknown; 
however these can be divided into two categories: protein kinases and transcription 
factors.  The protein kinases are ribosomal S6 kinase (RSK), mitogen activated protein 
kinase-activated protein kinases (MK), MAPK interacting kinases (MNK), and mitogen 
and stress activated protein kinases (MSK) (Figure 3).  The substrates of these protein 
kinases include CREB, Hsp27, and eIF-4E. Transcription factors that are targeted by 
MAPKs include: CCAAT enhancer binding protein (C/EBP) family transcription factor 
C/EBP homologous protein/growth arrest and DNA damage-155 (CHOP/GADD153), 
nuclear factor of activated T-cells (NFAT) and activator protein-1 (AP-1) [40].  These 
transcription factors are involved in transactivation of genes such as IL-2, IL-4, IL-5, 
CD40L, IL-1, CD40, CD30, TNF, etc. [40].  
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Classic and conventional MAPKs 
 Once the MAPK is activated, ERK1/2 has further downstream substrates it is 
able to activate.  When the cell is in a normal basal state, ERK1/2 and the components 
necessary for its activation are all located within the cytoplasm; however upon 
activation, much of the former cytoplasmic ERK1/2 will locate to the nucleus [47, 48].  A 
nuclear translocation sequence was found within the ERK1/2 insert domain [49].  When 
this domain became phosphorylated, it allowed for interactions with nuclear importing 
proteins, thought to then mediate translocation of ERK1/2 to the nucleus [44].  
Downstream substrates of ERK1/2 range from those in the cytoplasm (RSK, MNK), 
nucleus (ELK-1, N-FAT, c-fos, C-myc, STAT3), the cellular membrane (Syk, Calnexin) 
and even cytoskeleton (Paxillin) [44].  RSK activation is especially important, as it was 
able to regulate nuclear factors such as NF-κB.  RSK1 can phosphorylate both IκBα and 
IκBβ, which are inhibitory and keep NF-κB in the cytoplasm. Phosphorylation by RSK 
promoted their ubiquination and therefore allowed for NF-κB activity [50-52].  This could 
be important in leishmaniasis, where a robust TH1 response aids in parasite clearance.   
ERK and Leishmaniasis 
 ERK1/2 has been shown to be important in L. amazonensis infection, 
because its role is essential in cellular functions.  Boggiatto et al. [53] showed that 
ERK1/2 phosphorylation induced by the L. amazonensis was a location-targeted 
function that led to ERK1/2 upregulation post-infection of bone-marrow derived DCs.  
This ERK1/2 activation was shown to prevent CD40 surface expression and IL-12p40 
production of these cells, therefore inhibiting dendritic cell maturation [53].  MEK-
inhibitor treatment recovered the maturation of these cells in vivo [54, 55]. Mukbel et al. 
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[56] also showed that inhibiting MEK1/2 with PD98059 (and therefore its substrate 
ERK1/2) enhanced L. amazonensis killing via superoxide and NO production.  This 
directly implies ERK1/2 phosphorylation as mechanism through which the parasite is 
subverting the immune response. 
Localization of ERK signaling 
 ERK1/2 activation can promote ERK1/2 localization to the nucleus to activate 
nuclear substrates.  Because L. amazonensis localizes to the perinuclear regions within 
the host cell, and has been shown to induce ERK1/2 phosphorylation, this seems to 
support the idea that phosphorylated ERK1/2 that is close to the nucleus promotes 
activation of substrates that are beneficial for its survival.  Spatial localization is a well-
documented method by which signaling molecules are able to target signal transduction 
[41]. 
ERK scaffolds 
 ERK activation is augmented MEK and ERK interact via scaffolding proteins. 
This interactions modulates MAPK spatial fidelity. ERK1/2 is imported into the nucleus 
as a monomer, compared to cytoplasmic substrates activation; which requires an 
ERK1/2 dimer [57].  Spatial location of MAPK is essential for succinct targeting of 
downstream substrates.  Due to the breadth and contrasting effects of the MAPK 
pathway and ERK1/2 activation, a way to regulate and spatially target downstream 
effector molecules is essential.  Through spatial regulation ERK1/2 is able to activate 
specific downstream substrate targets [58].  
 Scaffolding proteins function as a dock for the rest of the proteins that will 
assemble at a complex.  Recently, the ‘ragulator’ complex, located on lipid rafts 
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composed of MP1, was described to contain ERK scaffold components p14, and p18 
[59].  Part of this ragulator is scaffolding proteins that were needed for L. amazonensis 
induced endosomal ERK1/2 activation.  MEK partner 1 (MP1) forms a tight binding 
interaction with p14, localized at the endosome, targeting MP1 and other binding 
partners towards late endosomes [60].  Downregulation of MP1 or p14 reduced 
endosomal ERK1/2 activation.  When MP1 was mislocalized to the plasma membrane, 
the effect of MP1 on ERK1/2 was ablated.  Boggiatto et al. [53] showed that preventing 
MP1 binding to MEK1/2 at the proline rich region, also prevented L. amazonensis–
mediated ERK1/2 phosphorylation.  Plasma membrane-activated ERK1/2 was 
completely functional.  This has provided further proof that L. amazonensis is able to 
signal from within the PV and mediate ERK1/2 activation.  Furthermore, it is possible 
that the spatial localization of PV and p-ERK1/2 allowed ERK to translocate into the 
nucleus for further activation of downstream nuclear substrates that promote parasite 
survival. 
Leishmania spp. use of host cell motor proteins 
 Leishmania uses host cellular pathways or molecules to promote infection. These 
localized pathways can be targeted through the use of motor proteins, such as dynein 
and kinesin, as well as using host transport pathways for needed nutrients. Other 
parasites have also been documented in their ability to use host cellular mechanisms. 
Trypanosoma cruzi, another member of the kinetoplastididae, engages host cellular 
pathways, as well as microtubules and the kinesin motor protein for transport of 
lysosomes from the host. As a result, T. cruzi vacuole biogenesis [61] occurred.  
Multiple intracellular protozoans are able to remodel the host cytoskeleton and localize 
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in perinuclear regions.  Perinuclear regions are important sites for pathogens because 
of the proximity of the endoplasmic reticulum and the Golgi, which can provide 
protozoans access to intracellular host nutrients. During L. amazonensis infection, 
parasite proximity to the nucleus could help determine whether there is signaling 
strength to nuclear anti-Th1 substrates after ERK1/2 phosphorylation.  L. amazonensis 
down-regulated surface expression of DC CD40 and production of IL-12, and doing so 
prevented dendritic cell maturation, proper antigen presentation and a strong TH1 
response [54].  How L. amazonensis is altering downstream substrates remains to be 
elucidated.  
Dynein 
 Dynein is cytoskeletal motor protein [62] that controls transport towards minus 
ends of microtubules [63], e.g. towards the nuclear region.  During Salmonella infection, 
ERK1/2 phosphorylated the intermediate chain of dynein in a MP1 dependent manner 
[64], to load cargo and transport it to the perinuclear area.  Because L. amazonensis is 
able to induce ERK1/2 phosphorylation, it is probable that it might be using dynein 
transport to place itself in a perinuclear localization. 
NADPH complex 
 In resting macrophages or neutrophils, the three cytosolic subunits are found 
in the cytoplasm, and these include p40phox, p47phox, and p67phox (Figure 4A).  
Once the subunit becomes activated, Rac, which is not considered a subunit but is 
equally important in the process, will exchange its GDP for a GTP becoming active.  
Rac1 is present in monocytes, while Rac2 is found in neutrophils [65].  This leads to 
activation of p47phox through its phosphorylation.  Once p47phox becomes 
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phosphorylated, it undergoes several conformational changes, and these are important 
because it then allows p47phox to bind to and interact with p22phox, which is located 
on the membrane whether in a resting or activated state.  The phosphorylation of 
p47phox allows this subunit to bring with it the other phox subunits, p40phox and 
p67phox, to the membrane.  Once these subunits translocate to the membrane, they 
are able to interact with the flavocytochrome/b558 (p22phox and gp91phox/NOX2).  As 
these subunits all assemble at the membrane, the complex is now fully functional and 
active, ready to start creating ROS.  Vesicles that are within the cell that contain this 
formed complex will now start to fuse with either the endosomes that contain the 
parasite/foreign antigen or with the plasma membrane. Once this fusion occurs, the 
complex is able to transport electrons from the NADPH that is present in the cytoplasm 
to oxygen present in the phagosomes, therefore creating O2- (superoxide) [66] (Figure 
4B). While fusion is thought to be a very important event for the microbicidal activity that 
gp91phox possesses, it is not by any means essential. In fact, the gp91phox/NOX2 can 
be activated without specifically fusing with membranes located on the surface but 
rather just within the granules themselves [67]. 
 p22phox is located on the membrane and has a stabilizing role for 
gp91phox/NOX2 while serving as a dock for the cytosolic subunits [66]. When these 
subunits converge, they will activate the complex (Figure 5).  p47phox translocates to 
the membrane due to cell stimulation and its subsequent phosphorylation, and as 
p67phox is bound to p47phox, then, when p47phox moves to the membranes so does 
p67phox.  Once at the membrane however, p67phox interacts with gp91phox/NOX2 
and leads to its activation, while Rac is also translocated to the membrane. p40phox, 
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which is the most recently discovered subunit and is also normally located in the 
cytoplasm, also translocates to the membrane. As of now, most data seems to place 
this p40phox in the regulatory category rather than being essential for NADPH 
activation.   
Akt, NADPH and Leishmania 
 Akt, also known as protein kinase B (PKB), has a major role in cell 
processes that involve proliferation, insulin and glucose metabolism, as well as having a 
role in apoptosis regulation.  The phosphoinositide 3-kinase (PI3K)/Akt pathway is 
activated when growth, cytokine, and kinase receptors induce the production of 
phosphatidylinositol 3, 4, 5 triphosphates (PtdIns (3, 4, 5) P3)/PIP3 by PI3K [68] which in 
turn activates PDK1, which then leads to Akt phosphorylation. Akt phosphorylates three 
different residues within p47phox, a subunit of the NADPH complex (Figure 6A).  
NADPH production of ROS is required for Leishmania spp. killing [56, 69].  Because 
ERK1/2 inhibition leads to NADPH complex formation and production of an oxidative 
burst within L. amazonensis-infected macrophages, it is possible that by inducing 
ERK1/2 phosphorylation the parasite is also preventing Akt activation.  This would 
prevent p47phox phosphorylation, NADPH complex formation, a lack of superoxide 
production and pathogen clearance. 
 L. amazonensis, pifanoi and major were all been reported [70] to engage and 
activate PI3K/Akt.  In these studies, these Leishmania spp. induced and engaged 
PI3K/Akt signaling to prevent apoptosis and, therefore, promoted parasite survival.  
Many protozoal pathogens use of this method of either blocking certain pro-apoptotic 
molecules or upregulating proteins that are anti-apoptotic, such as Akt promote their 
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own survival and intracellular persistence [71, 72].  To further validate their findings, 
Ruhland et al. [70] used small inhibitory RNAs to decrease levels of Akt present in the 
cell post Leishmania infection.  This caused the infected cells to revert back to 
promoting an apoptotic state rather than the parasite induced anti-apoptotic effect.  This 
signified that these Leishmania spp. seemed to be engaging the PI3K/Akt pathway to 
prevent apoptosis of cells they parasitized. Ruhland et al. [73]further reported that Akt 
signaling, when engaged by L. amazonensis, was responsible for the lack of IL-12 
response in macrophages infected with L. amazonensis.  When Ruhland et al. [73] used 
Akt inhibitors, they reversed the IL-12 block which implied that L. amazonensis was 
using the PI3K pathway preventing IL-12 production and promoting parasite survival.  
While these authors attributed parasite and Akt engagement as being responsible for an 
anti-apoptotic Akt role in infected cells, some authors suggested the opposite. Lodge et 
al. [74] proposes a different explanation for the role of Akt during Leishmania infection.  
Following Leishmania infection, phagocytosis promoted generation of superoxide, a 
precursor to several different reactive oxygen species during respiratory burst.  Lodge et 
al. [74] found that L. donovani avoids inducing superoxide production upon 
internalization, while also noticing that there was an absence of phosphorylation on 
NADPH cytosolic subunit p47phox.  p47phox phosphorylation is crucial to bring the rest 
of the cytosolic subunits to the membrane to bind with membrane-bound 
flavocytochrome and become activated; lack of p47phox phosphorylation will not lead to 
NADPH assembly.  Intracellular infection by L. donovani amastigotes, much like L. 
amazonensis infection, did not induce superoxide production.  Akt might prevent 
phosphorylation of p47phox.  PKC is known to phosphorylate and activate Akt, and 
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again, Akt has been shown to phosphorylate p47phox. L. donovani can inhibit PKC 
activity, therefore Akt is involved in preventing superoxide production in these cases.  
Whether the parasite is in fact inducing Akt phosphorylation to prevent apoptosis, or 
preventing Akt phosphorylation as a means to prevent p47phox phosphorylation and 
therefore NADPH formation, both or neither, remains to be determined.   
NADPH oxidase and Leishmania 
 Studies on knockout gp91phox-/- /NOX2-/- mice have shown that 
macrophages did not need ROS to kill L. major parasites, because these parasites were 
killed equally as well as their wild-type counterparts that do have gp91phox/NOX2 [75].  
Although ROS does have a key role in other Leishmania spp. killing, the main factor 
attributed with parasite killing was nitric oxide synthase.  Mukbel et al. [56] reported that 
not only was nitric oxide (NO) necessary for L. amazonensis parasite killing, but rather 
that it needed the production of superoxide for successful elimination of the parasite.  
Depending on the location and species, superoxide was required to 
complement/enhance macrophage killing ability.  Superoxide was not required for 
macrophages to induce L. major killing, but NO plays a more important role [56]. 
However in L. amazonensis both NO and superoxide are needed to properly kill the 
parasite.   
ERK1/2 and L. amazonensis altered host signaling 
 As a result of L. amazonensis infection, there is a marked increase in 
ERK1/2 phosphorylation within both macrophages and dendritic cells [54, 56]. This 
ERK1/2 phosphorylation promotes an immature DC phenotype and macrophages 
unable to clear intracellular L. amazonensis [56].  Upon binding of MP1 with MEK1/2, 
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ERK1/2 is tethered to the L. amazonensis PV and promotes further pro-parasite 
retention signals [53]. L. amazonensis utilizes the hosts scaffolding complex and 
because use of this complex provides spatial specificity, L. amazonensis brings ERK1/2 
next to the vacuole it inhabits (Figure 6B). Use of a PV/endosomal-specific p14/MP1 
scaffold complex promotes sustained ERK1/2 phosphorylation [53], alteration of the 
phagocyte oxidative burst [56] and leads to chronic infection [54, 53, 76, 77].  L. 
amazonensis has been shown to inhabit the perinuclear region within its PV [78-80].  
Pathogens benefit greatly from a perinuclear location due to nutrients available proximal 
to the golgi, but more importantly for Leishmania amazonensis because of nuclear 
substrate proximity.  ERK1/2 was shown to phosphorylate the IC chain of dynein in 
response to L. amazonensis infection.   It is conceivable that upon receptor ligation, L. 
amazonensis secretes a signal that indicates for ERK1/2 to begin to phosphorylate the 
IC of dynein at an increased level, thereby increasing its own chances of “hitching a 
ride” from the vacuole it has just entered towards the nucleus.  From previous data, it is 
known that if ERK1/2 is inhibited, parasite killing is increased and resumed through the 
use of ROS [56].   
 Therefore, L. amazonensis utilizes the hosts scaffolding complex and 
because use of this complex provides spatial specificity, L. amazonensis brings ERK1/2 
next to the vacuole it inhabits. L. amazonensis –mediated ERK1/2 activation prevents 
ROS production, perhaps through blockage of Akt phosphorylation of p47phox subunit 
of NADPH oxidase.  L. amazonensis multi-focal reliance on ERK activation to develop 
its intracellular niche provides a potential endosomal-targeted drug that could provide 
focused novel treatment of cutaneous leishmaniasis. 
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Figure 1. Life Cycle of Leishmania spp. Parasite entry into the human host occurs upon an 
infected sand fly ingesting a blood-meal and thereby injecting a plug of infectious promastigotes 
into the host.  Within the dermis, the parasite is phagocytized and transforms into the amastigote 
form.  Amastigotes divide and thrive within macrophages.  Once a naïve sand fly takes a blood-
meal from the infected host, it will ingest infected phagocytes.  These parasites will be released 
from the cell and the parasite replicates within the sand fly midgut as promastigotes.  Image from 
the CDC. www.cdc.gov/parasites/leishmaniasis/biology.html 
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Figure 2. Murine fibroblast infected with Leishmania amazonensis. Morphology of infectious 
Leishmania amazonensis promastigote.  There is not one, but rather several parasites in the 
process of infecting one single fibroblast.  The flagella is clearly visible as transformation into 
the amastigote stage begins after engulfment and entrance into the parasitphorous vacuole. 
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Figure 3. MAPK classic and unconventional pathways. MAPKs are a family of pathways 
united by a three-tiered module that starts with activating stimuli that leads to the activation of 
the MAPKKK, followed by MAPKK, and to MAPK.  Conventional MAPKs consist of ERK5, 
ERK1/2, p38, and JNK1/2/3.  Atypical MAPKs are ERK3/4, ERK7/8 and NLK.  Once MAPKs 
are activated they further phosphorylate and activate a plethora of substrates that located in the 
cytoplasm, nucleus, membrane and cytoskeleton.  Adapted from Cargnello et al. [44]. 
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Figure 4. NADPH phox subunits in basal and activated cells. A.)  During a resting state, the 
cytoplasmic subunits of p47phox, p67phox and p40phox are found free in the cytoplasm. 
Membrane subunit is flavocytochrome (p22phox and gp91phox/NOX2). B.)  Upon activation, 
Rac will activate cytoplasmic subunits. Once p47phox is activated through phosphorylation, it 
will travel to the membrane along with p67phox and p40phox.  It is only upon interaction with 
the membrane subunits of the NADPH system that the complex is activated and can produce 
ROS including to eliminate intracellular pathogens including L. amazonensis. 
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Figure 5. NADPH complex of bone marrow derived macrophages activated with Zymosan. 
A.) BMM not exposed to any stimulant, labeled with anti-p47phox (AF488) and gp91phox 
(AF568).  No activation NADPH oxidase activation, cells have basal levels of these proteins 
with no visualization of vesicles.  B.)  BMMs activated with Zymosan for 1 hour.  Zymosan is a 
strong activator of NADPH oxidase complex formation. Cell has delineated vesicles around 
engulfed particles of Zymosan. 
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Figure 6. Model. Leishmania amazonensis mediated ERK1/2 activation promotes parasite 
intracellular survival. Leishmania amazonensis is able to take of many pathways upon infection 
of host macrophages.  A.)  after a generic stimulus, the MAPK pathway is activated, or there can 
be activation and engagement of the PI3K pathway, which leads to Akt phosphorylation, and 
further phosphorylation of p47phox via Akt.  p47phox translocation to the membrane with the 
rest of the cytosolic subunits will bind with b558 and start the RB. B.)  1. MP1-MEK scaffolding 
complex is needed for parasite induced ERK1/2 phosphorylation.  2.  ERK1/2 phosphorylates 
intermediate chain of dynein essential for motor protein movement, thought to facilitate the PV 
access to the host nucleus.  3. ERK1/2 activating a downstream phosphatase.  This keeps Akt in a 
state of inactivation – and p47phox would not be activated, and therefore no activation of the 
NADPH oxidase complex or production of ROS, leading to intracellular parasite survival. 
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CHAPTER 2: Targeted extracellular signal-regulated kinase activation 
mediated by Leishmania amazonensis requires MP1 scaffold 
A paper published in Microbes and Infection1 
Paola M. Boggiatto a,1,2, Pedro A. Martinez a,2, Ashok Pullikuth c, Douglas E. 
Jones a, Bryan Bellaire b, Andrew Catling c,d, Christine Petersen a,e,* 
*Dr. Paola Boggiatto contributed to figures 1-5. Dr. Martinez and Dr. Boggiatto share primary 
authorship on this manuscript, and therefore it is part of this dissertation. 
 
Abstract 
Leishmania amazonensis infection promotes alteration of host cellular 
signaling and intracellular parasite survival, but specific mechanisms are poorly 
understood. We previously demonstrated that L. amazonensis infection of 
dendritic cells (DC) activated extracellular signal-regulated kinase (ERK), an 
MAP-kinase kinase kinase, leading to altered DC maturation and non-healing 
cutaneous leishmaniasis. Studies using growth factors and cell lines have shown 
that targeted, robust, intracellular phosphorylation of ERK1/2 from 
phagolysosomes required recruitment and association with scaffolding proteins, 
including p14/MP1 and MORG1, on the surface of late endosomes. Based on the 
intracellular localization of L. amazonensis within a parasitophorous vacuole with 
late endosome characteristics, we speculated that scaffolding proteins would be 
important for intracellular parasite-mediated ERK signaling. Our findings 
demonstrate that MP1, MORG1, and ERK all co-localized on the surface of 
parasite-containing LAMP2-positive phagolysosomes. Infection of MEK1 mutant 
fibroblasts unable to bind MP1 demonstrated dramatically reduced ERK1/2 
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phosphorylation following L. amazonensis infection but not following positive 
control EGF treatment. This novel mechanism for localization of intracellular L. 
amazonensis-mediated ERK1/2 phosphorylation required the endosomal scaffold 
protein MP1 and localized to L. amazonensis parasitophorous vacuoles. 
Understanding how L. amazonensis parasites hijack host cell scaffold proteins to 
modulate signaling cascades provides targets for antiprotozoal drug 
development. 
1 Reprinted with permission from Microbes and Infection, 2014, 1-9 
a Department of Veterinary Pathology, College of Veterinary Medicine, Iowa State University, Ames, IA 50010, USA 
b Department of Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, Iowa State University, 
Ames, IA 50010, USA 
c Department of Pharmacology, LSU Health Sciences Center, New Orleans, LA 70112, USA 
d Stanley S. Scott Cancer Center, LSU Health Sciences Center, New Orleans, LA 70112, USA 
e Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, USA 
 
 
Introduction 
Leishmania spp. cause an array of clinical disease from localized 
cutaneous lesions to fatal, visceralizing disease. These parasites reside within 
parasitophorous vacuoles (PV) or late endosomal/lysosomal compartments, 
which usually serve as a site of pathogen degradation. Leishmania amazonensis 
amastigotes are able to persist within these compartments and to date, the 
mechanisms of how this occurs have not been well-defined. Most studies have 
focused on understanding Leishmania parasite host interactions and the 
alteration in host signaling pathways upon initial entry. However, little is known 
regarding modulation of host signaling pathways by established parasites within 
PV. Endocytic-pathway internalization of receptors upon ligand binding is a 
common regulatory mechanism for receptor desensitization used by receptor 
tyrosine kinases (RTK) and G-protein coupled receptors [1]. Although this 
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process was initially thought to promote signal attenuation, presence of 
activated epidermal factor receptors (EGFR) and downstream effectors on 
endosome surfaces suggested the possibility of signaling from the endocytic 
pathway [2]. The concept of endosomes as signaling platforms for a variety of 
receptors has since been strengthened by subsequent studies showing signal 
attenuation during inhibition of endocytosis or subcellular mislocalization of 
endosomes [3-5]. Scaffold proteins provide sites for the formation of signaling 
complexes, enhance signal transduction, and provide specific sub-cellular 
localization [6].   
Signaling cascades rely on scaffolding complexes to provide a structure 
that ensures substrate interaction with their cognate signaling molecules in a 
temporally and geographically controlled manner [7]. Activation of the mitogen 
activated protein (MAP) extracellular regulated kinase (ERK) pathway from 
subcellular locations, including endosomal organelles, has been previously 
described [8]. Mediating this process are two scaffolding proteins, MEK Partner 
(MP) 1 and MAPK organizer (MORG) 1, [9,10]. MP1 contains a proline rich motif, 
which has a docking site for MEK1/2 [9]. Once scaffold bound, MEK1/2 
phosphorylation of ERK1/2 is augmented. Limited overexpression of MP1 leads 
to increased ERK1/2 activity, while down-regulation of MP1 leads to reduced 
ERK1/2 activity [6], demonstrating the importance of MP1 in the magnitude of 
ERK1/2 phosphorylation. We have previously shown that L. amazonensis 
promastigotes mediate ERK1/2 activation hours after infection once the parasite 
was internalized and within a phagosome [11]. We sought to determine how L. 
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amazonensis triggers ERK1/2 phosphorylation from within the parasitophorous 
vacuole, a phagosome-derived compartment. Based on the role of MP1 and 
MORG1 in regulating ERK1/2 phosphorylation from late endosomal 
compartments, we tested the hypothesis that these scaffolding molecules 
were involved in L. amazonensis -mediated ERK1/2 phosphorylation.  L. 
amazonensis- dependent ERK1/2 phosphorylation was actively mediated by the 
parasite, as heat-killed organisms were unable to mediate ERK1/2 activation. 
Moreover, parasites were found within late endosomal compartments, 
characterized by association with LAMP2.  These L. amazonensis -containing 
organelles co-localized with scaffold proteins MP1 and MORG1, previously 
demonstrated to serve as ERK1/2 scaffolds for endosomal activation. This did 
not occur in BMDC infected with Leishmania major. Through the use of a mutant 
fibroblast cell line in which MEK cannot bind to MP1, we demonstrated that L. 
amazonensis -meditated ERK activation was completely abrogated in cells 
unable to bind MEK to MP1. MP1 and MEK co-localization did not occur in L. 
amazonensis-infected mutant fibroblasts. Here we describe a novel Leishmania –
dependent mechanism of host signal modulation from the phagolysosomal 
compartment, mediated by host cell MAP kinase ERK1/2 scaffolding proteins 
MORG1 and MP1. 
Materials and Methods 
Bone marrow-derived dendritic cells (BMDC) 
BMDC were cultured from C3H/HeJ mice in the presence of 10 ng/ml of 
murine granulocyte-macrophage colony-stimulating factor (PeproTechInc., Rocky 
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Hill, NJ) as previously described [32]. At day 10 of culture BMDC were harvested 
for use and approximately 90% of the cells were positive for the DC marker 
CD11c as analyzed via flow cytometry. 
 
Mouse embryonic fibroblasts (MEF) 
Fibroblasts derived from MEK1_/_ mouse embryos from 129Sv/Ev mice 
(provided by Jean Charron, Universite´ Laval, Quebec, Canada, [12]) were 
reconstituted with wild type or L274S MEK1 [13] rat MEK1 using the Flp-In 
system (Invitrogen).  Clones expressing exogenous MEK1 at levels comparable 
to endogenous MEK1 in fibroblasts derived from wild type littermate animals 
were chosen for further study (supplemental Fig. 1). The L274S MEK1 mutant 
contains a leucine to serine change in the proline-rich sequence of MEK 
resulting in abrogation of MEK1 binding to MP1 [13]. These cells are hereafter 
referred to as “WT” and “LS” cells. WT and LS cells were cultured in vitro with 
0.1% Hygromycin in DMEM (Gibco) supplemented with 10% Fetal Bovine Serum 
(Atlanta Biologicals, Lawrenceville, GA). 
 
Parasite culture, infection and treatments 
Culture of L. amazonensis (MHOM/BR/00/LTB0016) parasites was 
performed as previously described [14]. For in vitro promastigote experiments, 
stationary phase L. amazonensis promastigotes were used. Where indicated, 
parasites were labeled with CellTracker Orange CMRA (Invitrogen,Carlsbad,CA). 
Parasites in PBS were incubated with 0.1 mM solution of CellTrackerOrange 
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CMRA dye for 15 min at room temperature, washed, and re-suspended in PBS. 
For heat-killed experiments, L. amazonensis promastigotes were diluted to the 
desired concentration and then incubated at 65oC for 1 h and placed on ice for at 
least 20 min prior to use. Where indicated, BMDC were treated with Pertussis 
toxin (100ng/ml) (Calbiochem, San Diego, CA), and washed immediately prior to 
infection. After infection, coverslips seeded into parallel cultures were removed 
and counted for PTX treated vs. mock treated cells infected with L. amazonensis, 
indicating that PXT treatment of cells in this way did not interfere with parasite 
infection.  BMDC, WT and LS cells were incubated at 34 _C, 5% CO2and 
infected with L. amazonensis promastigotes at a parasite to cell ratio of 3:1. 
 
Immunoblot 
To make whole cell lysates, 3 _ 106 BMDC or fibroblasts were re-
suspended in 400 ml of 1x cell lysis buffer (Cell Signaling Technologies, Beverly, 
MA), supplemented with 1 mM phenylmethylsulphonyl fluoride (PMSF) and a 
protease inhibitor cocktail (Roche, Indianapolis, IN) immediately prior to use. 
Samples were incubated on ice for 15 min and then centrifuged at 16,000x g  for 
10 min at 4oC. Supernatants were collected as whole cell lysates and stored at    
-80oC until further use. Protein content of all cell extracts was determined via 
BCA protein assay (Pierce, Rockford, IL) according to manufacturer’s 
recommendations, and all samples were normalized to 1 mg/ml using distilled 
water. Samples (20-30 µg of protein) were denatured in 1x loading buffer and 
electrophoresis was performed on a 12% SDS-PAGE gel.  Gels were blotted 
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onto polyvinylidene fluoride membranes (PVDF), blocked with 5% bovine serum 
albumin, and probed with antibodies specific for phospho-ERK, total-ERK1/2 
(1:1000) (Cell Signaling, Beverly, MA) and b -actin (1:5,000) (Sigma, St. Louis, 
MO). Signal was detected with horseradishperoxidase (HRP)-conjugated goat 
anti rabbit antibody (1:20,000) (Jackson, West Grove, PA) using West 
chemiluminescent substrate (Pierce, Rockford, IL) and exposed to 
autoradiography film (MidSci, St. Louis, MO). 
 
Immunofluorescence analysis 
1x106 BMDC were plated onto glass tissue cover slips.  BMDC were 
infected with CellTracker Orange CMRAlabeled L. amazonensis promastigotes at 
an MOI of 3:1 and incubated at 34 _ C with 5% CO2.  Coverslips were harvested 
and fixed with 4% paraformaldehyde in phosphate buffered saline (PBS). BMDC 
were permeabilized with 0.1% saponin in PBS. Coverslips were incubated with 
rabbit anti-MP1 (Santa Cruz Biotechnology), rabbit anti-MORG1 (Serotec), rabbit 
anti-pERK1/2 (Cell Signaling, Beverly, MA), and rabbit anti-LAMP2 
(eBiosciences) at a 1:100 dilution in 0.1% saponin. After incubation, cover slips 
were washed and incubated with rabbit anti-mouse Cy2-conjugated antibody 
(Jackson ImmunoResearch Laboratories, West Grove, PA) at a 1:200 dilution in 
0.1% saponin. BMDC were counter-stained with DAPI according to 
manufacturer’s instructions (Molecular Probes, Eugene, OR), mounted using 
MOWIOL (Calbiochem, La Jolla, CA) and viewed using an Olympus IX71 
inverted epifluorescence scope (Olympus America Inc., Center Valley, PA). Co-
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localization analyses were carried out using MacBiophotonics ImageJ software 
and confirmed by sequential scanning confocal microscopy using an Olympus 
IX81 inverted scope. For WT and LS MEF cell experiments, cells were infected 
and processed similar to BMDC. After incubation with primary antibodies as 
above, coverslips were washed and incubated with anti-donkey AlexaFluor 488, 
594, and 680 (Life Technologies, CA) at 1:200. Fibroblasts were counterstained 
and mounted with hardmount DAPI, Vectashield, (Vector Laboratories, 
Burlingame, CA) and analyzed using a Leica Confocal Scope (TCS SP5 X (Leica 
Microsystems, Exton, PA) and analyzed via the Leica Application Suite 
Software (Leica Microsystems, Exton, PA). 
 
Acquisition and processing of images 
In addition to primary acquisition by the Leica and Olympus software, 
images were converted to Adobe Photoshop CS3. Brightness and contrast were 
improved for visualization in print form and figures arranged in GraphPad Prism 5 
as appropriate and Photoshop CS3, exported as tiff files. 
 
Ethics statement 
All animal experiments were approved by the Iowa State University 
IACUC (log number 3-06-6071-M). 
 
Statistical analysis 
Statistical significances were analyzed using Prism4 (Graph Pad Software 
! 44!
Inc., La Jolla, CA). Differences between groups were determined using Student’s 
t -tests or one-way ANOVA. p-values below 0.05 were considered statistically 
significant. 
 
Results 
Live L. amazonensis promastigotes required for ERK phosphorylation 
Previous studies have shown that multiple signaling events appear to be 
triggered by Leishmania internalization, but are not necessarily triggered by the 
parasite itself [15,16]. We wanted to demonstrate that ERK1/2 phosphorylation 
observed after L. amazonensis infection was an active, parasite mediated, 
response and not a normal response to particle internalization. To test this we 
treated bone marrow-derived dendritic cells (BMDC) with either live or heat-killed 
L. amazonensis promastigotes and collected lysates at the indicated time points 
(Fig. 1) and measured ERK1/2 phosphorylation using western blot. Live L. 
amazonensis promastigotes resulted in significantly increased ERK1/2 
phosphorylation as compared to heat-killed parasites (Fig. 1), supporting our  
hypothesis of a parasite-driven event rather than a response to internalization of 
parasite material. 
 
L. amazonensis in late endosomal compartments and developmental progression 
to amastigotes 
It has previously been shown that upon phagocytosis, Leishmania 
promastigotes were contained within a double membrane-bound parasitophorous 
! 45!
vacuole (PV) [17]. In DC, newly-formed, Leishmania -containing phagosomes 
rapidly acquired late-endosomal markers including LAMP-1 and -2 [18]. During 
this time promastigotes transformed into amastigotes.  Based on this information, 
we wanted to determine the compartment and parasite developmental stage that 
corresponded with ERK1/2 phosphorylation. We infected BMDC with 
fluorescently labeled L. amazonensis  promastigotes and harvested cells on 
coverslips at 2, 3 and 4 h post-infection. We evaluated the phagosomal 
compartment via LAMP-2 immunolabeling and epifluorescent microscopy. L. 
amazonensis parasites were found within compartments that tightly delineated 
the shape of the parasite (Fig. 2 A, first panel). Green, punctate staining 
indicated presence of LAMP-2 (Fig. 2 A, second panel) on the surface of this 
compartment. These data confirm previous findings indicating that PV maturation 
occurs within 1 hour of infection into a LAMP-2 positive, late 
endosomal/phagosomal compartment [18].  Previously we described that 
although ERK activation in DC occurred rapidly after exposure to L. amazonensis 
amastigotes (seconds to minutes), we found peak ERK activation after exposure 
of L. amazonensis promastigotes to DC occurred 3-5 h post-exposure [11]. 
Although New World species of Leishmania take several days to transform from 
promastigotes to amastigotes, others have found that L. amazonensis transforms 
relatively quickly [15]. To further characterize parasite development within 
infected BMDC, we sought to determine the percentage of promastigotes and 
amastigotes before (2 h post-infection) and during ERK1/2 activation (4 h post-
infection). L. amazonensis- infected BMDC cultured on coverslips were 
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harvested 2 and 4 h post-infection and analyzed via light microscopy. 
Promastigotes and amastigotes were differentiated based on morphology, 
presence or absence of a flagellum, and size. As expected, while promastigotes 
predominated within infected cells at 2 hr post-infection, there was a significant 
increase in the number of intracellular amastigotes by 4 h post-infection (Fig. 2 
B). These data suggest that at the time of observed ERK1/2 phosphorylation, L. 
amazonensis parasites were found within late endosomal/lysosomal 
compartments, and were undergoing expected transformation into amastigotes. 
 
Intracellular-phosphorylated ERK co-localizes with L. amazonensis 
We have previously shown that L. amazonensis promastigote-infected 
BMDC had significant and robust ERK1/2 phosphorylation 3-4 hr post-infection 
as compared to mock treated or L. major -infected BMDC [11]. In addition, we 
demonstrated that at this time, parasites were within late endosomal 
compartments (Fig. 2 A). Based on these findings, we hypothesized that L. 
amazonensis-mediated ERK1/2 activation may localize to this compartment. To 
test this hypothesis we infected BMDC with fluorescently labeled L. amazonensis 
promastigotes and identified the location of phosphorylated ERK1/2 using 
intracellular immunofluorescence analysis and  sequential scanning confocal 
microscopy. Green cytosolic staining indicated phospho-ERK1/2 in close 
apposition with parasites within BMDC (Fig. 3 A). Immunofluorescence particle 
co-localization analysis showed that phospho-ERK1/2 co-localized with L. 
amazonensis promastigotes (red) at 3 h post infection (Fig. 3 A, fourth panel), 
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this also occurs at 2 and 4 hours post-infection (data not shown). These data 
corroborate our previous hypotheses indicating L. amazonensis-mediated 
ERK1/2 phosphorylation occurred from intracellular, parasite containing, 
compartments. 
 
Scaffold proteins MP1 and MORG1 associated with L. amazonensis-containing 
organelles 
MP1 and MORG1 are structural proteins shown to serve as a scaffold for 
ERK1/2 phosphorylation on the surface of late endosomal compartments [9,10]. 
While MP1 directly connects to late endosomes via hetero-dimerization with p14, 
MORG1 can only join the scaffold complex on late endosomes through 
a direct interaction with MP1 [10,19]. As phospho-ERK1/2 co-localized with 
intracellular L. amazonensis parasites within late endosomal compartments, we 
hypothesized that these scaffold proteins may help tether ERK1/2 to parasite 
containing late-endosomes for activation by MEK1/2. We again utilized BMDC 
infection with fluorescently labeled L. amazonensis and sequential scanning 
confocal microscopy to determine association between MORG1, MP1 and 
parasite containing compartments. We found a cytosolic distribution for MORG1 
co-localized with intracellular parasites (Fig. 4 A).  We similarly found that MP1 
co-localized with L. amazonensis (Fig. 4 B). This immunofluorescent labeling was 
shown to be host-MP1 or MORG1 specific and not due to specific or nonspecific 
labeling of the parasite (supplemental Fig. 1 ) MORG1 and MP1 were associated 
with intracellular L. amazonensis and may mediate observed L. amazonensis -
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dependent activation of ERK1/2. 
 
G protein-coupled receptor upstream of  L. amazonensis-dependent ERK1/2 
phosphorylation 
Little is known regarding regulation and recruitment of MP1 or MORG1 to 
late endosomal compartments. However, of the two, MORG1 appears to show 
more selectivity as it is only recruited to endosomal ERK1/2-phosphorylation 
scaffolds after G protein-coupled receptor (GPCR) activation [1]. To determine 
whether GPCR activation was required for L. amazonensis -mediated ERK1/2 
phosphorylation, perhaps correlating with MORG1 localization to the signaling 
scaffold, we pre-treated BMDC with Pertussis toxin (PTX), which binds to the 
alpha subunit of Ga -i/o subfamily of G proteins and prevents their activation. 
When BMDC were pre-treated with PTX and then infected with L. amazonensis  
promastigotes, we observed a significant decrease in ERK1/2 phosphorylation as 
compared to untreated, infected cells (Fig. 5 ). PTX treatment did not decrease 
parasite infection in these cells (data not shown). These data suggest that 
activation of the Gaαi/o subfamily was involved in mediating enhanced L. 
amazonensis dependent ERK1/2 activation, possibly through recruitment of 
MORG1 to late endosomal compartments. 
 
L. amazonensis-mediated ERK activation requires MP1-MEK binding 
Co-localization of MORG1 and MP1 at the surface of L. amazonensis  PV 
corresponding to ERK1/2 phosphorylation suggested that this scaffold was 
! 49!
needed for L. amazonensis mediated ERK phosphorylation from the PV. We 
wanted to determine if MP1-MEK binding was required for parasite mediated 
ERK phosphorylation. We infected LS cells, in which MEK1 lacks the ability to 
interact and bind to MP1 (supplemental Fig. 2 ) and assessed the level of ERK 
phosphorylation at 2 and 4 h post-infection. The absence of MP1-MEK 
interaction resulted in significantly reduced ERK1/2 phosphorylation following L. 
amazonensis infection of LS cells as measured via western blot (Fig. 6 A and B) 
when compared to WT cells. To confirm that abrogation of ERK1/2 
phosphorylation was specific to endosomal, MP1- mediated signaling and did not 
affect ERK1/2 signaling from other cellular locations, we stimulated LS and WT 
cells with epidermal growth factor (EGF). EGF triggers plasma membrane-
localized ERK1/2 phosphorylation, independent of MP1-based scaffolds [20] . 
EGF treatment resulted in similar ERK phosphorylation between LS and WT cells 
(Fig. 6 C). These findings indicate that MP1e MEK interaction is required for L. 
amazonensis-mediated ERK1/2 phosphorylation. 
 
L. amazonensis/MP1/p-MEK1/2 co-localization lacking in LS mutant cells 
Cellular scaffolds are critical for bolstering both signal amplitude and 
signal location. We have demonstrated that the MP1-scaffold is important for the 
presence and amplitude of L. amazonensis-mediated ERK1/2 phosphorylation. 
We additionally wanted to assess the level of MP1/MEK/L. amazonensis 
interaction following L. amazonensis promastigote infection of LS cells. 
Immunofluorescence and confocal microscopy were performed to identify the 
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location of MP1, MEK, and parasite nuclei. At 4 h post-infection we observed 
significantly more phospho-MEK in WT cells compared to LS cells (Fig. 6 D, 
second panel). Co-localization of MP1 and phospho-MEK was observed in WT 
and not in LS (mutant) cells (Fig. 6 E). Number of cells with red and green signal 
in the same space (p-MEK and MP1) were counted at 100x magnification for 
both WT and LS cells, using three coverslips, 300 cells per coverslip, for a total 
of 900 cells counted per time post-infection, for both 2 and 4 h post L. 
amazonensis infection. Significantly more WT cells had overlapping signal 
as compared to LS cells at both times points, although more pronounced by 4 h 
post-infection (Fig. 6 F). Z-stack analysis showed co-localization of parasite 
nuclei with MP1 and p-MEK activation (supplemental Figs. 3,4 ). Together these 
findings demonstrate that following L. amazonensis infection, MP1-MEK 
interaction is required for endosomal MEK phosphorylation and parasite 
localization to the MP1 scaffold with subsequent downstream robust 
phosphorylation of ERK1/2. 
 
Discussion 
L. amazonensis modulates DC maturation through activation of ERK1/2 
[11] , altering a critical step for promotion of a T helper 1 immune response and 
clearance of L. amazonensis infection [21-23]. It was previously unknown if L. 
amazonensis-mediated ERK1/2 phosphorylation was an active process by the 
parasite or produced by cell entry via phagocytosis.  Treatment of BMDC with 
heat-killed L. amazonensis promastigotes resulted in significantly decreased 
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ERK1/2 phosphorylation compared to BMDC treated with live parasites (Fig. 1 ), 
indicating that ERK1/2 phosphorylation was dependent on viable, intracellular L. 
amazonensis parasites. Due to the delay in ERK1/2 phosphorylation, and the 
predominance of amastigotes at the time points corresponding to ERK1/2 
phosphorylation (Fig. 2 ), we propose that it is the amastigote form of the parasite 
that is responsible for initiating this signaling cascade. Amastigotes have been 
previously shown to alter host cell processes, including signaling, to establish 
infection and persist within the phagolysosome [24]. Further studies are required 
to determine the identity of putative amastigote factors that may meditate ERK1/2 
phosphorylation.  We and others have previously reported activation of MAP 
kinase ERK1/2 during L. amazonensis  infection [11,25], which we showed did 
not occur after L. major infection of BMDC. In this manuscript we show co-
localization of phosphorylated ERK1/2 with intracellular L. amazonensis (Fig. 3 A 
and B), suggesting activation of this signaling cascade from the membrane of an 
intracellular vesicle. While the plasma membrane is the canonical site for signal 
transduction initiation, signaling from intracellular organelles has been described 
for the MAP kinase pathway [8] . Scaffold proteins have emerged as critical 
mediators in the regulation of ERK1/2 signaling from subcellular compartments. 
These molecules act by binding one or more kinases and regulating association 
with other kinases or substrates, enhancing their activity and specificity as well 
as determining specific subcellular localization for that signaling complex [6]. 
MP1 and MORG1 are two such scaffold proteins shown to mediate ERK1/2 
activation from late endosomal compartments. We show that MP1, MORG1, or 
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both are recruited to parasite-containing organelles and mediate phosphorylation 
of ERK1/2. Previous studies have shown that MORG1 is recruited to endosomal 
compartments under specific conditions, specifically when G-protein coupled 
receptors (GPCR) are stimulated [10]. Inhibition of MORG1 recruitment results in 
decreased ERK1/2 phosphorylation following receptor stimulation, as MORG1 
functions to enhance activation of this kinase from late endosomal compartments 
[10]. Treatment of L. amazonensis infected BMDC with Pertussis toxin (PTX), a 
known Gαi/o subunit inhibitor, led to a decrease in ERK1/2 phosphorylation as 
compared to non-treated cells (Fig. 5 ). This observation suggests a role for 
Gαi/o signaling and MORG1/MP1 scaffold-dependent modulation of ERK1/2 
phosphorylation following L. amazonensis infection (Fig. 7 ).  Given these 
findings, we sought to assess the role of another scaffold protein required for 
endosomal ERK1/2 signaling, MP1. MEK-mutant MEF LS cells showed nearly 
complete abrogation of ERK1/2 phosphorylation, indicating that interaction of 
MP1 with MEK1 is essential for parasite mediated ERK1/2 phosphorylation (Fig. 
6 ). However, when these cells were stimulated with epidermal growth factor 
(EGF), which triggers ERK1/2 signaling from the plasma membrane, ERK1/2 
phosphorylation remained intact. These findings indicate that there is no 
deficiency in pan-ERK1/2 signaling (Fig. 6 C) in these mutant cells. Confocal 
microscopy demonstrated that in LS cells neither MP1 and phospho-MEK1/2 nor 
MP1 and L. amazonensis co-localize(Fig.6D). These data demonstrate that L. 
amazonensis-mediated ERK1/2 phosphorylation requires a functional endosomal 
MEK1/2-MP1 scaffold for both signal strength and location of signal to the 
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parasitophorous vacuole. The p14/MP1 scaffold complex was recently been 
shown as important for host-pathogen interaction in a Salmonella infection 
model, as lack of function of this complex induced increased bacterial replication 
[26]. These findings suggest that the p14/MP1 complex has a positive role in 
clearing Salmonella  infection. In contrast, our current and previous findings [11], 
suggest that the MP1 scaffolding complex enhances maintenance of L. 
amazonensis intracellular infection.  It is likely, therefore, that the p14/MP1 
complex may play different roles in determining the course of infection depending 
on pathogen virulence. While Salmonella results in sub-acute to acute infection, 
L. amazonensis persists within the host, and must alter its environment in order 
to do so [27]. The p14/MP1 complex, which is present in the endosome, serves 
in anchoring MEK1/2 to the late endosomal surface and augmenting the 
activation of ERK1/2, which is then free to activate further downstream 
substrates that inhibit BMDC maturation (Fig. 7). This complex has also has 
recently been shown to be part of the “ragulator” complex, composed of p14, p18 
and MP1, necessary for activation and targeting of mTORC1 to the lysosomal 
surface [28]. Activation of mTORC1 is important for regulation of autophagy 
during nutrient-rich conditions [29]. It has been previously demonstrated that L. 
amazonensis mediated induction of autophagy in macrophages increases 
parasite load, suggesting perhaps that L. amazonensis utilizes this pathway in 
other ways as well to promote its survival [30].  Understanding whether 
autophagy is altered through this signaling scaffold complex during L. 
amazonensis infection is a potential additional area of study.  Inhibition of the 
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p14/MP1 scaffolding complex could lead to both reduced autophagy and reduced 
ERK1/2 phosphorylation in L. amazonensis-infected macrophages with 
subsequent increased parasite clearance.  L. amazonensis -mediated ERK1/2 
phosphorylation utilized a novel means of spatial targeting to the endosomal 
surface, a scaffold formed by the modular proteins MP1, MORG1 and likely 
others. Moreover, MP1/MEK1/2 interaction was required for parasite-dependent 
ERK1/2 signaling at an endosomal location. We previously demonstrated that 
ERK1/2 phosphorylation following L. amazonensis infection leads to impaired DC 
maturation and decreased parasite removal [11,31].  Inhibition of ERK1/2 
phosphorylation restores DC maturation in vitro and partial recovery in vivo [11]. 
Our findings provide a specific, scaffold-mediated, mechanism of L. 
amazonensis-induced ERK1/2 signaling. This level of target and location 
specificity would allow for development of drug targets that specifically modify 
parasite mediated-ERK1/2 phosphorylation and enhance host immune function 
and parasite clearance during L. amazonensis infection. 
 
Appendix A. Supplementary data 
Supplementary data associated with this article can be found in the online 
version at http://dx.doi.org/10.1016/j.micinf.2013.12.006 . 
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Figure 1. Live L. amazonensis promastigotes are required to promote 
phosphorylation of the MAP kinase ERK1/2. BMDC were treated with live or 
heat killed L. amazonensis promastigotes and incubated at 34 _C with 5% CO2.  
BMDC were harvested at the indicted time points and total cell lysates were 
made. Samples were analyzed via western blot for phosphorylated and total 
ERK1/2. Densitometry values were normalized to total ERK and then to non-
infected controls. Densitometry analysis of at least three different experiments 
and representative blot are shown; error bars denote +SEM; *p < 0.05. Paola 
Boggiatto. 
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Figure 2. L. amazonensis parasites found within LAMP2-positive 
compartments where amastigotes predominate four hours post-infection. 
BMDC in 24 well plates containing glass coverslips were infected with 
CellTracker Orange CMRA-labeled or unlabeled L. amazonensis promastigotes. 
Coverslips were recovered at indicated time points, fixed and stained. (A) 
Sequential scanning confocal microscopy (x60, oil) analysis of BMDC infected 
with L. amazonensis (red, arrow), and intracellular LAMP2 (green) at 3 h post-
infection. Nuclear material was stained with DAPI (blue). Detailed image of one 
cell from overlay. Control labeling for LAMP2 with secondary antibody only in 
supplemental data. Data representative of at least three experiments. (B) 
Coverslips analyzed via light microscopy (x100, oil) to stage parasites. Stage 
was determined by presence or absence of flagellum and parasite diameter. 
Graph indicates the percentage of cells infected by either or both forms. 
Representative images for both time points are shown. Data from at least three 
different experiments; error bars denote +SEM; *p < 0.05. Paola Boggiatto. 
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Figure 3. Co-localization of L. amazonensis and intracellular 
phosphorylated-ERK1/2. 
BMDC in 24 well plates containing glass coverslips were infected with 
CellTracker Orange CMRA-labeled L. amazonensis promastigotes. Sequential 
scanning confocal microscopy (x60, oil) analysis of L. amazonensis (red) and 
intracellular phospho-ERK1/2 (green) at 3 h post-infection. Co-localization of L. 
amazonensis and phospho-ERK1/2 is observed (fourth column, areas of yellow). 
Data representative of images from at least three different experiments. Paola 
Boggiatto. 
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Figure 4. Co-localization of the scaffold proteins MORG1 and MP1 with L. 
amazonensis within infected BMDC.  
BMDC were infected with CellTracker Orange CMRA-labeled L. amazonensis 
promastigotes. Sequential scanning confocal microscopy (x60, oil) analysis of L. 
amazonensis (red) and intracellular (A) MORG1 or (B) MP1 (green) at 3 h post-
infection. Detailed images of one infected cell. Comparison overlay image of L. 
major-infected BMDC 3 h post-infection shown on far right. Images indicate 
areas of co-localization between parasite (arrows) and MORG1 and MP1, 
indicated by areas of yellow. Paola Boggiatto. 
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Figure 5. Pertussis toxin treatment reduces L. amazonensis-dependent 
ERK1/2 phosphorylation and MORG1 co-localization. BMDC were infected 
with L. amazonensis promastigotes and left untreated or treated with Pertussis 
toxin (100ng/ml) and incubated at 34 _C with 5% CO2. BMDC were harvested at 
the indicted time points and total cell lysates were made. Samples were analyzed 
via western blot for phosphorylated and total ERK1/2. Densitometry values 
were normalized to total ERK and then to non-infected controls. Densitometry 
analysis of at least three different experiments and representative blot are 
shown; error bars denote +SEM, *p <0.05. Paola Boggiatto. 
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Figure 6. L. amazonensis mediated ERK1/2 phosphorylation requires the 
MP1 scaffold complex located specifically at the endosome, and co-
localization of MP1 and p-MEK1/2 in WT and LS cells.  
Wildtype (WT) and MEK mutant fibroblasts (LS cells) were infected with L. 
amazonensis parasites at the indicated time points. Whole cell lysates were 
collected and analyzed via western blot for phosphorylated-ERK1/2 as well as for 
total ERK1/2. (A) Densitometry analysis for at least four independent 
experiments. (B) Representative western blot showing robust increase in ERK1/2 
phosphorylation in L. amazonensis-infected WT cells as compared to LS cells. 
(C) Representative western blot showing similar ERK phosphorylation in LS and 
WT MEF cells following EGF stimulation. Error bars denote +SD, *p < 0.05. (D) 
WT and LS MEF cells infected with L. amazonensis. Confocal microscopy (x60, 
oil) analysis of MP1 (green), p-MEK1/2 (red), L. amazonensis and fibroblast 
nuclei (DAPI, blue) at four hours post-infection. Co-localization of MP1 and p-
MEK1/2 is observed (top panel, fourth column, areas of bright orange/yellow). 
(E) Co-localization of MP1 and p-MEK in WT cells. Inset is a zoom magnification 
showing co-localization of MP1, p-MEK, and close proximity of L. amazonensis 
(blue nuclei). (F) Counts of number of cells with co-localization of MP1 and p-
MEK1/2. Values in indicate number of cells containing co-localization events of 
MP1/pMEK1/2. Data are from three different experiments, 300 cells counted per 
coverslip, for a total of 900 cells counted per time-point. 
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Figure 7. Model. Proposed Leishmania entry into BMDC with MORG1/MP1 
scaffolding complex assembly at the phagolysosome.  
(A)Upon uptake of L. amazonensis into a BMDC, in conjunction with Ga-i/o 
GPCR signaling (blue), the parasite is housed initially within an early 
phagosome, typically characterized by markers such as Rab5 and transferrin 
receptor (TfR). (B) As maturation into a phagolysosome occurs, there is an 
increase of late endosomal markers such as LAMP2 and Rab7. (C) At this stage, 
when the parasite has begun transformation into the amastigote form, that 
downstream of with Gα-i/o GPCR signaling, proposed host and parasite factors 
stimulate interaction between MORG1, MP1 and MEK1/2 at the phagolysosome 
surface. This interaction augments L. amazonensis-mediated MEK 
phosphorylation of ERK at the phagolysosome surface. This in turn allows p-ERK 
to translocate to the nucleus and further activate downstream substrates which 
prevent dendritic cell surface expression of CD40 production of IL-12 p40 and 
modulates DC maturation, while promoting DC survival.  
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CHAPTER 3: Leishmania amazonensis-mediated ERK1/2 activation 
prevents NADPH oxidase assembly in infected macrophages through 
modulation of Akt 
 Pedro A. Martinez b, Hailie Fowler c and Christine A. Petersen a,c* 
A paper to be submitted for publication in Cell Communication and Signaling 
Abstract 
Leishmania amazonensis, the causative agent of disseminated cutaneous 
leishmaniasis, modulates macrophages to promote its intracellular survival. 
Parasite-mediated phosphorylation of extracellular signaling regulated kinase 
(ERK1/2) has been previously shown to promote chronic infection by preventing 
dendritic cell maturation.  Inhibition of ERK1/2 led to increased L. amazonensis 
intracellular killing within infected macrophages.  One possible mechanism for 
enhanced parasite killing is by restoration of the respiratory burst through the 
NADPH oxidase complex assembly.  How parasite-induced ERK1/2 alters 
intracellular parasite removal is unknown.  We demonstrate Akt activation as 
critical for anti-Leishmania ROS production.  Use of Akt inhibitor III on bone 
marrow derived macrophages infected with Leishmania major demonstrated an 
ablation of superoxide formation.  The use of a specific ERK1/2 inhibitor, U0126, 
in RAW 264.7 macrophages and BMMs restored the ability of these cells to 
produce reactive oxygen species in response to infection with L. amazonensis.  
This indicates for the first time that parasite-induced ERK1/2 was required for 
prevention of NADPH oxidase complex membrane assembly and ablation of 
superoxide production.  
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Introduction  
Leishmania amazonensis causes chronic intracellular infection by 
subverting the host immune response.  It has been previously demonstrated that 
the synergistic combination of superoxide with nitric oxide forms peroxynitrite [1] 
which is essential for macrophage killing of L. amazonensis [2].  Unlike 
Leishmania major which promotes a healing immune response; L. amazonensis 
upregulated ERK1/2 from the endosome [3] as a means of survival and evading 
host macrophage responses.  Macrophage and neutrophils produce superoxide 
in response to pathogen recognition [4], which is a major component of the 
respiratory burst (RB).   
Assembly of the nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase complex, needed for a successful RB is composed of three cytosolic and 
two membrane-bound subunits [5] in neutrophils and macrophages.  While the 
GTP-binding protein Rac is involved in the activation process, it is not exclusive 
to NADPH complex and is involved in other cellular functions as well.  These 
macrophage subunits, labeled phox for their membership in the phagocyte 
oxidase group, are p47phox, p67phox, and p40phox in the cytosol [6].  
Membrane subunits are p22phox and gp91phox/NOX2, which together form the 
heterodimeric flavocytochrome, b558 [6].  Successful activation of the complex 
requires cytosolic subunit translocation and association with the flavocytochrome.  
Activation of the NADPH complex is essential to aid in the removal of intracellular 
foreign antigens.  Defects in these subunits have been shown to cause chronic 
granulomatous disorder.   
Inhibition of ERK1/2 has shown to enhance L. amazonensis killing in 
macrophages, while superoxide inhibition abrogated this response [2].  In this 
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previous study, ERK1/2 activation was implicated in the lack of superoxide 
production in response to L. amazonensis infection.  Studies have shown that 
inhibition of the phosphatidylinositol 3-kinase (PI3K) pathway, through the use of 
the non-specific biochemical inhibitor Wortmannin, was able to alter superoxide 
production post L. amazonensis-infection (Gibson-Corley, et al, in submission).  
Akt/Protein Kinase B (PKB) is an immediately downstream target of PI3K.  Akt is 
responsible for a variety of cellular functions that include proliferation, survival, 
translation, growth, etc. [7]. Three isoforms of Akt exist, (Akt1, Akt2, and Akt3) 
and all of these isoforms have been shown to be phosphorylated at the same 
common sites, Thr-308 and Ser-473 [8], upon activation. 
  Akt has been shown to be a key kinase that phosphorylates the p47phox 
subunit of NADPH oxidase.  This phosphorylation step promoted p47phox 
association with p22phox after migration to the flavocytochrome at the 
phagosome membrane.  Various serine residues on p47phox have been 
reported to drive NADPH oxidase assembly and activation.  Akt has been 
reported to phosphorylate both S304, and S328 [9] on p47phox leading to 
NADPH complex formation. 
p47phox phosphorylation has been shown to be a key activator for 
complete NADPH oxidase complex activation [10].  Once p47phox was activated 
through phosphorylation at S304, and S328 [9], it translocated with p67phox and 
p40phox to the phagosomal membrane to interact with p22phox.  This interaction 
caused a conformational change within p22phox that allowed it to interact with 
p47phox.  Rac phosphorylation of p67phox is also an essential step for proper 
NADPH complex formation.  Upon completion, the complex can successfully 
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transport electrons from NADPH present in the cytoplasm to oxygen present in 
the phagosomes, creating superoxide [6].  
Leishmania spp. have been reported to engage PI3K. However, results 
and possible mechanisms regarding the effect of this engagement on the 
parasite were conflicting.  Infection of cells by L. amazonensis, L. major, and L. 
pifanoi, engaged and activated host cell PI3K/Akt [11].  In these studies Akt 
activation of macrophages containing Leishmania spp. was shown to prevent 
host cell apoptosis, thereby promoting parasite intracellular survival.  In fact, 
Ruhland et al. [11] showed that decreased Akt levels in infected cells by use of 
small inhibitory RNAs reverted these to a pro-apoptotic state.  This indicated 
Leishmania spp engaged Akt to prevent apoptosis of infected cells.  Lodge et. al 
[12] however reported that upon infection of peritoneal macrophages (PEM) with 
Leishmania donovani amastigotes, there was a lack of p47phox phosphorylation. 
L. donovani has been reported to inhibit PKC. PKC is able to phosphorylate and 
activate Akt; thus inhibition of PKC would also inhibit Akt. L. donovani may 
therefore prevent NADPH oxidase p47phox phosphorylation via inhibiting PKC 
activity.  Lodge et al. [12] concluded that Akt might be involved in preventing 
superoxide formation through parasite manipulation of the cellular response.  
Superoxide evasion mechanisms are also employed by Leishmania pifanoi.  L. 
pifanoi is able to promote heme degradation [13], which has a direct impact on 
the maturation state of gp91.  gp91 relies on heme to properly mature from its 
premature 65-kDa [13] state. Hence, heme degradation through parasite-
mediated increase of heme oxygenase 1, allows L. pifanoi to evade superoxide 
production due to improper gp91 maturation. 
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Based on these previous studies in which Leishmania spp actively employ 
different mechanisms to evade superoxide production, we sought to understand 
how L. amazonensis prevented its intracellular removal in an ERK1/2-dependent 
manner.  L. amazonensis Is known to use p-ERK1/2 for survival mechanisms, 
and therefore parasite mediated p-ERK1/2 is potentially involved in inhibiting 
superoxide production.  Our hypothesis was that parasite induced ERK1/2 
prevented phosphorylation of p47phox, or p40phox via Akt, and subsequently 
prevented NADPH complex formation, oxidative burst and parasite removal. We 
found that infected bone-marrow derived macrophages (BMMs) and RAW 264.7 
macrophages did not have co-localization of NADPH subunits p47phox and 
p91phox post-L. amazonensis infection.  However, upon pretreatment of these 
cells with ERK1/2 inhibitor U1026, subunit co-localization was detected in L. 
amazonensis infected cells.  This implicates parasite mediate p-ERK1/2 as being 
potentially involved in the prevention of superoxide production.  RAW 264.7 and 
BMMs also had restored ability to produce superoxide.  Inhibiting Akt in L. major-
infected macrophages led to complete ablation of ROS production.  This novel 
data indicates that ERK1/2 activation due to parasite infection was directly 
interfering with superoxide production through prevention of p47phox migration to 
the membrane subunits of NADPH oxidase. 
 
Materials and Methods 
Cell lines and Bone Marrow-Derived macrophages (BMMs) 
Bone marrow-derived macrophages (BMMs) were obtained from 4-12 
week old male C57BL/6 mice.  Cells were stimulated with L929 cell-conditioned 
media for 10 days and then harvested as described previously [14].  Cells were 
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plated onto 24-well culture plates to be analyzed via immunofluorescence and 
confocal microscopy.  RAW cells, passage 15, were a kind gift of Lee-Ann Allen, 
University of Iowa. 
 
Parasite culture and infection 
L. amazonensis strain (MHOM/BR/00/LTB0016) and L. major 
(MHOM/IL/80/Friedlin) were cultured in Grace’s media as described previously 
[15-17] at 28oC.  For in vitro experiments stationary phase parasites were used.  
RAW 264.7 murine macrophage cells, and BMMs were infected with a 3:1 
parasite to cell ratio for the time indicated at 34oC temp and 5% CO2. 
 
Western Blot analysis 
Cell lysates were obtained by re-suspending 1.5 x 106 BMM or RAW 
264.7 cells with 1x of 400µl of cell lysis buffer (Cell Signaling Technologies, 
Beverly, MA).  A protease and phosphatase cocktail inhibitor (Thermo Scientific, 
Rockford, IL) was added immediately prior to use.  Samples were incubated on 
ice for 15 min and centrifuged at 16,000 x g for 10 min at 4oC.  Pellet was 
discarded, and supernatants collected, and stored at -80oC.  Protein 
concentration was determined via BCA protein assay (Pierce, Rockford, IL) and 
samples normalized to 1mg/ml.  Samples containing 20-30µg of protein were 
denatured with 4x loading buffer for 5 min in boiling water.  Gel electrophoresis 
was performed on a 12% SDS-PAGE separating gel, and a 4% stacking gel. 
Gels were blotted onto a polyvinylidene fluoride membrane (PVDF), blocked with 
5% bovine serum albumin (BSA) for 1 hour.  Antibodies specific to phospho-
ERK, total-ERK1/2, phospho-Akt, and total-Akt were used at a 1:1000 dilution 
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(Cell Signaling, Beverly, MA). Signals were detected via incubation with 
horseradish-peroxidase (HRP)-conjugated goat anti-rabbit antibodies (1:20,000) 
(Jackson ImmunoResearch, West Grove, PA) and addition for 5 minutes of the 
SuperSignal west chemiluminescent substrate (Pierce, Rockford, IL).  Signal was 
detected on radiography film. 
 
Immunofluorescence labeling 
RAW 264.7 macrophages and BMMs were plated onto 24-well plates at a 
density of 5x105. Corresponding wells for IFA contained coverslips and were 
incubated at 37oC with 5%CO2.  Cells were activated with LPS (100ng/ml) and 
IFN-γ (5ng/ml) 4 hours prior to infection.  Cells were treated with Akt inhibitor 
(EMD Chemicals, San Diego, CA) (10µm/ml) or MEK inhibitor U0126 (Cell 
Signaling, Beverly, MA) (25µm/ml) when indicated two hours prior to infection.  At 
2 and 4 hours post-infection, cells were harvested and fixed with 4% 
paraformaldehyde for 15 minutes, and subsequently washed three times with 
phosphate buffered saline (PBS).  Cells were permeabilized with 0.1% saponin in 
PBS for 10 minutes and washed with PBS.  Cells were then blocked for 1 hour 
with 5%BSA in PBS and host donkey serum.  Antibodies were added at a 1:100 
dilution overnight at 4oC.  Primary antibodies included rabbit p47phox, mouse 
gp91phox, mouse p47phox, rabbit p40phox, mouse p-p40phox, rabbit p-
p40phox, goat p67phox (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit 
b245/p22phox, rabbit p-Akt, (Abcam, Cambridge, MA), and rabbit p-Akt (Cell 
Signaling Technology, Danvers, MA).  Coverslips were washed with PBS three 
times and incubated at a 1:200 dilution in 0.1% saponin of secondary antibodies 
that included donkey anti-rabbit AF488, donkey anti-mouse AF568, donkey anti-
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mouse AF488, donkey anti-rabbit AF568, donkey anti-goat AF647, and donkey 
anti-goat AF568 (Life Technologies, Grand Island, NY).  Coverslips were washed 
with PBS and mounted with DAPI anti-gold Fade stain per the manufacturer’s 
instructions (Life Technologies, Grand Island, NY). 
Confocal microscopy and co-localization analysis were performed using a 
Zeiss LSM510 confocal microscope (Carl Zeiss Microscopy, Jena, Germany, 
provided through NIHSI grant 1 S10 RR12916-01) and Imaris software (Bitplane, 
Zurich, Switzerland). 
 
Reactive oxygen species production via the CellROX assay 
RAW 264.7 macrophages and BMMs were prepared as described for 
immunofluorescence.  30 minutes prior to harvesting, CellROX (Life 
Technologies, Grand Island, NY) was added to the assayed wells at a 
concentration of 5µm.   
 
Superoxide production via Nitro Blue Tetrazolium (NBT) assay 
 RAW 264.7 macrophages and BMMs were plated onto 24-well plates at a 
density of 5x105 that contained coverslips and incubated at 37oC with 5%CO2.  
Nitro Blue Tetrazolimide (NBT) (Sigma, St. Louis, MO) was used to determine 
superoxide production.  NBT tablets were dissolved in 1mL of di H20 and 30µl of 
NBT was added to wells for 90 minutes incubated at 37oC with 5%CO2.  
Coverslips were fixed with methanol, and counterstained with Eosin.  Formazan 
precipitates, which indicate superoxide formation, were counted at 300 cells per 
coverslip from three different coverslips, for a total of 900 counted cells, with a 
light Zeiss microscope. 
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Statistical Analysis 
 Statistical analyses were performed via GraphPad Prism Software using a 
one-way ANOVA.  * designates significance with a p-value less than <0.05. Error 
bars denote +standard error of the mean. 
 
Results 
Leishmania amazonensis failed to recruit NADPH oxidase cytosolic subunits to 
phagosome-parasitophorous vacuoles  
 It is known from previous reports that L. amazonensis infection fails to 
engage macrophages to produce superoxide in significant levels that would 
enable parasite resolution.  Therefore, we wanted to verify the location of the 
NADPH subunits through confocal microscopy as a positive control.  NADPH 
cytosolic subunit translocation to the membrane is required for proper activation 
of the NADPH complex.  L. amazonensis is known to cause persistent and 
chronic disease [18] due to a lack of a strong TH1 response.  ERK1/2 activation 
leads to improper dendritic cells maturation [18], and to a lack of intracellular 
parasite removal [2].   Cytosolic NADPH oxidase subunit translocation to the 
membrane leads to superoxide formation [19].  Therefore cytosolic as well as 
membrane subunits were labeled via immunofluorescent markers to observe via 
confocal microscopy for the presence or lack of NADPH oxidase assembly on the 
phagosome membrane.  As a positive control, RAW 264.7 murine macrophages 
were exposed to opsonized Zymosan (OpZ) for 60 minutes.  gp91phox/NOX, 
part of the membrane subunit [20] was labeled and visualized with AF568 
(Figure 1A), p47phox and p67phox (both cytosolic subunits) were labeled 
respectively with AF488 and AF647 (Figure 1B,C).  The merge of the images 
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indicated co-localization was present (Figure 1D).  p67phox is located at the 
cytosol, therefore its delineation around vacuoles with membrane subunits 
indicated NADPH assembly. 
BMM which were previously activated with IFN-γ and LPS were infected 
with L. major for four hours and labeled for gp91phox/NOX2 (Figure 2B), and 
p67phox (2C).  These images identified strong translocation of cytosolic NADPH 
oxidase subunit(s) to coincide membrane subunits on parasite containing 
vacuoles (Figure 2D). BMM were also infected with L. amazonensis for four 
hours.  Coverslips were labeled with DAPI (Figure 2E), gp91phox (AF568) 
(Figure 2F), and p47phox (AF488) (Figure 2G).  No subunit co-localization was 
observed, although vacuole formation was apparent (Figure 2H).  Leishmania 
major does not cause chronic skin lesions and is resolved by the host immune 
response.  This response is partly due to superoxide production by macrophages 
[21].  Therefore, BMMs and RAW 264.7 macrophages should show NADPH 
subunit co-localization in response to L. major infection.  Subunit co-localization 
in parasite containing vacuoles would indicate an initiation of the cascade leading 
to the respiratory burst responsible for parasite decrease. Vacuole formation 
occurred equally in response to L. amazonensis and L. major indicating 
phagocytosis of both parasites, however only in L. major containing vacuoles did 
NADPH complex assembly occur.  This was verified via co-localization of 
p47phox, p67phox (both cytosolic subunits) with gp91phox/NOX2.  Overlay of 
these images indicated translocation to the same areas, and therefore 
association.  These data suggested that L. amazonensis may prevent p47phox 
from flavocytochrome association at the PV membrane, thereby preventing 
complex assembly. 
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NADPH assembly is recovered after ERK1/2 inhibition in Leishmania 
amazonensis infected RAW 264.7 and BMM 
L. amazonensis mediated ERK1/2 phosphorylation has been shown to 
require a specific endosomal scaffold for increased amplitude and 
phagolysosomal location by [3].  Inhibition of ERK1/2 was previously shown to 
induce increased parasite killing in BMM [2].  The specific role of ERK in 
preventing NADPH oxidase assembly at the L. amazonensis PV remains 
unclear.  gp91phox/NOX2 and p47phox, NADPH oxidase membrane and 
cytosolic subunits respectively co-localize to parasite containing vacuoles in 
RAW 264.7 cells post U0126 inhibition (Figure 3).  To ensure this was not an 
artifact seen only in a laboratory cell line, primary cells were used as verification 
(Figure 3E-H).  Arrows in panels E-H indicate areas of parasite containing 
vacuoles, and a clear delineation of all the subunits at the vacuole membrane.  
BMM were similar to RAW 264.7 cells, infected with L. amazonensis and treated 
with U0126, a MEK inhibitor.  p47phox (AF568) (Figure 3F) and p22phox 
(AF488) and additional membrane subunit is shown (Figure 3G). Labeled 
subunits and PV membrane delineation was observed by both subunits, as was 
co-localization (Figure 3H, arrows).  Upon ERK1/2 inhibition, p47phox 
assembled at parasite containing vacuoles. 
 
Leishmania major requires Akt for superoxide formation 
 It has been previously shown by Lodge [12] that L. donovani is able to 
cause PKC inhibition.  PKC is able to phosphorylate Akt and cause its activation.  
Therefore, L. donovani might be inhibiting PKC, and thereby Akt to prevent 
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p47phox phosphorylation.  This would be a mechanism that explains the lack of 
superoxide that is seen upon phagocytosis of this parasite. Based on these 
previous results we hypothesized that the L. major infection response of ROS 
production by macrophages might be dependent on Akt.  We used confocal 
microscopy of L. major infected macrophages labeled with CellROX which 
detects ROS and indicates this via a red color change.  Briefly, we induced ROS 
production with Menadione (Figure 4A) and then used the N-acetylcysteine 
(NAC) superoxide inhibitor (Figure 4B) to ensure this assay was indeed specific 
to superoxide production.  To determine the role of Akt in this system, we used 
an Akt inhibitor to block Akt activation, and we hypothesized that this would 
prevent downstream translocation of p47phox to the L. major PV membrane.  As 
measured by confocal microscopy and visualization of red CellROX signal, there 
is minimal ROS production in L. amazonensis infected cells (Figure 4C), 
compared to a strong superoxide production in macrophages infected with L. 
major (Figure 4D). Figure 4E-F show a zoom of L. major infected cells. ROS 
production clearly forms around the parasite containing vacuole.   
In comparison to the strong ROS induction in L. major infected cells 
(Figure 5A) there was, an almost complete ablation of superoxide/ROS signal in 
L. major-infected cells treated with Akt inhibitor (Figure 5B). There were 
significantly less L. major infected cells that produced ROS when treated with Akt 
inhibitor that were positive for CellROX labeling as compared to non-treated cells 
infected with L. major. A count of three separate coverslips, 300 cells per 
coverslip demonstrated a significant shift from strong production of ROS to 
minimal production (Figure 5C).  Cells were counted as positive for ROS based 
on presence of color change.  Non-infected cells did not have any color change, 
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positive results were compared to the basal level in non-infected cells.  There 
were differences in levels of ROS production in non-infected and infected cells. 
This was verified by observing ROS completely encircling the parasitophorous 
vacuole (Supplementary Data – Video 1).   Parasites were also denoted via DAPI 
nuclei staining and confirmed via Z-stack 3D reconstruction (Supplementary Data 
– Video 2). Based on these findings, Akt activation may be important for 
Leishmania-intracellular removal.  L. amazonensis could, therefore, also use Akt, 
albeit differently, in order to promote infection.  L. amazonensis is likely 
modulating Akt activation or its ability to phosphorylate p47phox to prevent 
translocation of p47phox to the PV membrane. 
 
Bone marrow derived macrophages with U0126 inhibited ERK1/2 
signaling regain superoxide production 
In previous experiments we showed NADPH complex membrane 
formation was restored in macrophages treated with U0126 inhibitor.  However, 
this was not quantitative, and therefore we sought to prove this via another 
method, as well as to quantify the number of macrophages that produce ROS in 
response to L. amazonensis infection post-treatment with the U0126 inhibitor.  
RAW 264.7 cells infected with L. amazonensis failed to produce a significant 
amount of superoxide (Figure 6B) similar to non-infected cells (Figure 6A) as 
quantified via CellROX and cell counting.  Treatment with U0126 inhibitor 
however yielded a significant change (Figure 6C).  U1026 treated macrophages 
restored superoxide production in response to L. amazonensis to levels almost 
as equal to those seen in macrophages that are naturally resistant to L. major 
infection because of clearance through superoxide (Figure 6D).   
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Superoxide production is restored in RAW 264.7 cells infected with 
Leishmania amazonensis post U0126 treatment  
To confirm results observed via the CellROX assay, the NBT assay was 
used to detect the presence of superoxide.  Superoxide formation is indicated by 
the presence of formazan precipitates (dark purple/blue deposits).  Superoxide 
was not detected in non-infected cells (Figure 7A) while it was strongly induced 
in zymosan treated cells (Figure 7B) as expected. Similar to the CellROX assay, 
inhibition of ERK1/2 with U1026 showed a sharp increase in superoxide 
production (Figure 7D) compared to non-treated U0126 cells (Figure 7C).  
These levels are almost equal to superoxide levels made in response to L. major 
infection (Figure 7E).  Akt inhibitor was used to determine whether superoxide 
production in L. major infected cells was due to Akt potentially activating 
p47phox. Since L. major does not induce sustained p-ERK1/2 and thereby is not 
preventing Akt activation based on our hypothesis, Akt was inhibited. RAW 264.7 
macrophages showed an increase in superoxide production in L. major infected 
macrophages and a strong downregulation of superoxide in L. major infected 
macrophages (Figure 7F) treated with Akt inhibitor Results showed an almost 
complete abrogation of superoxide production in L. major infected macrophages.  
Similar results were observed in BMM (Figure 7G, H). Video of parasite via z-
stack is in (Supplemental Figure 1) and of reactive oxygen species surrounding 
a PV with L. major (Supplemental Figure 2). 
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Discussion 
 While it has been previously shown that ERK1/2 was required as a means 
for L. amazonensis survival [2] and that ERK1/2 inhibition leads to an increase in 
superoxide, how this was happening has been speculative at best.  In this study, 
we showed that Akt seems to mediate the relationship between ERK1/2 
upregulation and superoxide downregulation in response to L. amazonensis 
infection.  Previously, PD98059 was used to show ERK1/2 inhibition [2], which 
led to enhanced parasite killing.  However, PD98059 has been shown to not only 
inhibit ERK1/2, but can also inhibit other pathways.  U0126 has been shown to 
have a 100 fold higher affinity for MEK than PD98059 [22]. By using U0126 ERK 
inhibition to restore superoxide production in macrophages infected with L. 
amazonensis we show that the lack of O2- was much more likely to be due to 
ERK1/2 and not to interaction or engagement of other pathways attributed to the 
use of PD98059 inhibition. 
L. major does not normally cause non-healing ulceration, and in fact, most 
mice are resistant to persistent cutaneous lesions caused by L. major.  
Resistance is attributed to a strong immune response that leads to a TH1 
polarized phenotype.  Contrary to L. amazonensis, L. major does not engage 
ERK1/2 for survival, and has not been shown to use this MAPK protein to 
establish intracellular infection as is the case with L. amazonensis.  Therefore, 
our postulation of ERK1/2 being manipulated by the parasite to promote its 
survival by preventing p47phox phosphorylation through Akt, also required L. 
major analysis.  Because macrophages infected with L. major do induce a strong 
respiratory burst, during L. major infection, NADPH oxidase complex was 
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properly activated.  This required p47phox activation, mediated by Akt.  Upon Akt 
inhibition, almost complete abrogation was seen in ROS production (Figure 5).   
Previous studies used Wortmannin as an inhibitor of the PI3K pathway. 
This inhibitor is once again not solely specific to Akt inhibition, and is quite 
promiscuous in regards to the proteins it can interact with and inhibit.  Akt 
inhibitors have the perk of being highly specific to solely Akt, therefore more likely 
that any response observed after use of these inhibitors, was due to Akt 
inhibition, and not an upstream substrate.  Our results are not necessarily 
opposing to a previous study on Akt and Leishmania spp. by Ruhland et al [11].  
Ruhland et al. [11] reported that they observed phosphorylation levels of Akt.  We 
also observed Akt phosphorylation in L. amazonensis infected RAW 264.7 
macrophages (data not shown).  Our results however, diverged in explanation of 
how the parasite might utilize Akt to promote survival.  Ruhland et al. [11] pointed 
to previous reports of pathogens promoting anti-apoptotic states in the cells they 
infect as a means to promote their own survival, and had similar findings.  Our 
results from a primary cells, could be more similar to what might be occurring in 
vivo.  Also, the interaction of Akt in preventing the production of superoxide might 
very well be highly dependent on the timing, and intensity of phosphorylation.   
Lodge et al. [12] previously reported that L. donovani does not induce 
superoxide production in macrophages.  However, because L. donovani does 
inhibit PKC, a direct activator of Akt, the parasite may exploit this mechanism as 
a means to prevent ROS production.  L. donovani, similar to L. amazonensis 
failed to induce p47phox activation or translocation to the membrane.  Based on 
this data, it highly suggestive that the parasite actively disrupted activation of 
p47phox.  In this present study, we reported that inhibition of ERK1/2 led to 
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macrophages that highly produce ROS.  While we did not quantify levels of 
parasite killing in these L. amazonensis infected cells, their numbers of ROS 
producing were almost equal to those cells producing ROS in response to L. 
major, which may be sufficient to kill the parasite.  Further studies would benefit 
from detecting specifically which sites are being blocked on p47phox to prevent 
activation, or conversely which parasite induced substrate downstream of 
ERK1/2 is modulating Akt.  This information would provide us with a target that if 
properly inhibited, could in theory restore the ability of the macrophage to fend off 
infection through ROS, thereby ameliorating the clinical signs observed with L. 
amazonensis. 
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Figure 1. RAW 264.7 macrophage cells stimulated with Zymosan as a 
positive control for recruitment of NADPH oxidase subunits to the 
phagosome membrane. 
RAW 264.7 macrophages exposed to Zymosan for 1 hour and subsequently 
labeled for NADPH subunits.  A.) gp91phox/NOX2 labeled with AF568 (red).  B.)  
p47phox subunit labeled with AF488 (green).  C.) p67phox subunit labeled with 
AF647 (gray).  D.)  Merge.  Scale bar 8.00 µm, magnification was taken at x60 
magnification with oil. 
 
 
 
 
 
 87 
 
 
 
 
 
 
 
 
 88 
Figure 2.  Leishmania major infected bone marrow derived macrophages 
show co-localization of NADPH subunits while Leishmania amazonensis 
infected macrophages failed to colocalize. 
Bone marrow derived macrophages obtained from BL/6 mice labeled with 
antibodies for p47phox,p67phox, and gp91phox/NOX2. A-D. BMMs infected with 
L. major.  E-H represent BMMs infected with L. amazonensis.  A.) DAPI stained 
nuclei of BMMs and parasites.  B.) gp91phox/NOX2 subunit of the complex 
labeled with AF568 (red). C.) p67phox of the NADPH complex stained with 
AF647 (grey).  Arrows indicates areas of increased p67phox D.) Merge of all 
images. Scale bar is 7.00µm. E.) BMM DAPI stained nuclei.  L. amazonensis 
nuclei also visible.  F.) BMM gp91phox/NOX2 labeled with AF568 (red).  G.) 
BMM p47phox was labeled with AF488 (green).  H.) Merge of images.  Scale bar 
is 5.00µm and images were taken at x60 with oil. 
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Figure 3. NADPH subunits are able to co-localize post Leishmania 
amazonensis infection after U0126 treatment in RAW 264.7 cells and bone 
marrow macrophages 
RAW 264.7 macrophages and BMMs were infected with L. amazonensis for 4 
hours.  Cells were pre-treated with the U0126 inhibitor. Panels A-D represents a 
single enlarged macrophage of RAW 264.7 cells infected with L. amazonensis. 
1.) DAPI nuclear stain.  B.) gp91phox/NOX2 labeled with AF568 (red).  C.) 
p47phox labeled with AF488 (green).  D.) Merge of all 3 panels.  Scale bar 
represents 4.00e4 µm.  Images taken at x60 with oil.  Panels E-H represent 
BMMs infected with L. amazonensis and treated with the U0126 inhibitor.  E.) 
BMM stained with the nuclear stain DAPI.  F.) NADPH subunit p47phox was 
labeled with AF568 (red).  G.) NADPH subunit p22phox was labeled with AF488 
(green).  H.) Merge of images. Arrows indicate areas of parasite containing 
vacuoles.  Cells were imaged at x60 with oil, scale bar representative of 3.00e4 
µm. 
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Figure 4. Macrophages infected with L. amazonensis and L. major  had 
differential ROS production. 
RAW 264.7 macrophage cells were treated with CellROX, which detects ROS 
being produced by a colorimetric change ( red).  A.) RAW 264.7 cells were 
treated with Menadione for 1 hour at a concentration of 100µM.  B.) RAW 264.7 
cells were treated with Menadione at a concentration of 100µM for an hour, plus 
NAC at  a 50µM concentration. C-D represents cells infected with L. 
amazonensis  and L. major. C.)  RAW 264.7 macrophages infected with L. 
amazonensis for 4 hours. Scale bar represents 10µm.  D.)  RAW 264.7 cells 
infected with L. major for 4 hours.  Scale bar represent 10µM. E-F represent a 
zoom image of ROS congregating at the PV infected with L. major.                   
E.)  Representative image of DAPI stained nuclei of RAW 264.7 cells with 
stained L. major nuclei as well.  B.) ROS localizes to parasite infected vacuoles.  
Arrow indicates parasite location. 
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Figure 5.  Leishmania major strongly induced ROS after infecting RAW 
264.7 macrophages.  Respiratory burst was ablated when Akt inhibited. 
RAW 264.7 macrophages were infected with L. major, or with L. major  and Akt 
inhibitor.  A.) Reactive oxygen species ( red).  Scale bar represents 10µm.  B.) 
RAW 264.7 macrophages treated with Akt inhibitor before L. major infection. 
Scale bar represents 10µm. C.)  Counts of cells that showed red color change.  
900 cells were counted per treatment. Results represent data from three 
coverslips. Asterisk indicates p-value less than 0.05. 
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Figure 6.  Bone marrow derived macrophages infected with L. amazonensis 
had diminished ROS production recovered upon addition MEK1/2 inhibitor. 
Bone marrow derived macrophages were infected with L. amazonensis, and 
labeled with CellROX (red) on untreated cells, infected cells, and infected cells 
with U0126.  A.) Control non-infected BMM representing basal levels of ROS 
production, blue indicates DAPI stain of nuclei.  B.) BMMs infected with L. 
amazonensis for 4 hours.  C.) BMMs infected with L. amazonensis for 4 hours in 
cells pre-treated with U0126. magnification of x60 oil.  D.)  Counts of cells with 
red color change.  900 total cells counted. These results represented three 
coverslips from which 300 cells were counted. Asterisk indicates p-value less 
than 0.05. 
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Figure 7.  Superoxide production in Leishmania amazonensis infected RAW 
264.7 macrophages, treated with and without U0126 inhibitor. 
Cultures were incubated for 1.5 hrs. with NBT in RAW264.7 macrophages. Cells 
were counterstained with Eosin.  Analyzed via x60 oil. 
 A.) Non-infected macrophages.  B.)  Zymosan stimulated cells.  C.) L. 
amazonensis infected macrophages.  D.) U0126 treated macrophages infected 
with L. amazonensis. 
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CHAPTER 4: Host motor protein Dynein influences perinuclear location of 
Leishmania amazonensis 
 Pedro A. Martinez b, Andrew Catling c and Christine A. Petersen a,c* 
A paper to be submitted to Cellular Microbiology 
Abstract 
Leishmania amazonensis has been shown to activate MAPK ERK1/2, 
which is one of the factors leading to chronic infection within an infected host.  
Various pathogens were shown to hijack host cell motor proteins to establish 
successful intracellular infection.  Previously, L. amazonensis was shown to 
downregulate surface expression of CD40, a secondary activation signal receptor 
of dendritic cells that was restored upon ERK1/2 inhibition.  It was proposed that 
CD40 expression was altered by parasite-induced ERK activation at the level of 
nuclear transcription. The perinuclear area is an attractive location for the 
parasitophorous vacuole as this locale may promote ERK nuclear translocation 
to further strongly act upon substrates that activate anti-TH1 mechanisms 
including regulation of CD40 expression.  Here, we investigate whether the 
parasite is using dynein, a host motor protein, in order to promote its localization 
towards the perinuclear region of the cell.  We find that colchicine and dynein 
inhibition 1.5 hrs after cellular infection prevented parasite perinuclear 
localization, however use of these inhibitors did not affect the ability of the 
parasite to infect macrophages.  Very little is known regarding downstream 
targets upon L. amazonensis-mediated ERK1/2 phosphorylation. An infection-
specific ERK substrate was elucidated, cPLA2. This work demonstrates for the 
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first time how L. amazonensis may use ERK1/2 activation to target its 
parasitophorous vacuole to a perinuclear location and activate downstream 
targets of ERK. 
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c Department of Pharmacology, LSU Health Sciences Center, New Orleans, Louisiana 70112, 
USA 
* Author for correspondence (christine-petersen@uiowa.edu) 
 
 
Introduction 
 Pathogens in general are well known for their ability to use host 
mechanisms that developed for defense to their advantage.  The kinetoplastidae 
family includes amongst them intracellular parasites such as Trypanosoma cruzi, 
and Leishmania spp.  Common traits amongst these species are that they 
possess kinetoplastids, and can cause chronic infection that can lead to 
clearance, or host death depending on factors such as the infecting species, and 
the host immune response.   
 Cells need to transport cellular cargo towards and away from the nucleus 
for proper function. Because vesicles, proteins, organelles, and RNA are not 
necessarily manufactured at the site of where they will function, mechanisms in 
the cell exist to transport these to their proper location for effective function [1].  
This movement in location can transport cellular cargo to be destroyed by 
ubiquination, or to communicate cell signaling processes. These transports are 
driven by motor proteins, that can either use actin filaments (myosins) or 
microtubules (MTs) which primarily use motor proteins dynein and kinesin [2]. 
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Because there is constant cargo transport occurring within cells, the key motor 
proteins responsible for the distances these cargo travel (measured in microns) 
is mostly attributed to dynein and kinesin [3, 4].  These two motor proteins have a 
very similar function but ‘travel’ in opposite directions across the cell.  Motor 
proteins are mainly powered by ATP and function in either an anterograde 
manner – meaning the cargo is transported towards the plus end of the MT which 
tends to be at the cell periphery [5], or in a retrograde manner, which means 
cargo is transported towards the minus end of the MT located towards the 
nucleus and often found associated with a microtubule organizing center (MTOC) 
[6]. Dynein is known to function in a retrograde manner, and kinesin in an 
anterograde manner. 
 Because of the intricate relationship between motor proteins and cellular 
transport, it is not surprising that pathogens have found a way to exploit this 
mechanism.  Bacteria to viruses [2] hijack the MT cytoskeleton, using dynein to 
reach the nucleus upon infection [7], and kinesin when they need to exit the cell 
to further infect host cells [8].   For example S. typhimurium is able to 
downmodulate the amount of kinesin in a host cell and thereby it can control the 
dynamics of membrane exchanges of their vacuoles [2].  Adenoviruses have 
been shown to have a direct interaction with motor protein subunits [9], while 
herpes simplex virus (HSV1) actually has the ability to recruit dynein [10] to 
promote its transport in the cell.   
Dynein is a large multimeric complex composed of two heavy chains, two 
intermediate chains, two light intermediate chains, and several more light chains 
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described in Pfister et. al [11].  The intermediate chains have been reported to be 
essential for binding light chains, and binding the dynactin complex involved in 
cargo, regulation and MT binding [4]. This binding of the dynactin complex 
mediated by the IC not only improves dynein processing [12] but also is required 
for dynein to attach to any type of cargo for transport [2]. 
ERK1/2 has been previously shown to be able to phosphorylate the 
intermediate chain (IC) of dynein [13] through epidermal growth factor (EGF), or 
nerve growth factor (NGF) stimulation [14] at serine 81.  Inhibition of ERK1/2 
leads to superoxide rescue, which aids in parasite killing, restoration of DC 
maturation (essential for proper antigen presentation), and the ability to properly 
assemble the phagocytic complex that is lacking in normally infected 
macrophages with L. amazonensis.  Interestingly, it has also been proven that 
parasite mediated ERK1/2 activation occurs from the surface of the 
parasitophorous vacuole, mediated by the MP1 scaffolding complex [15].  When 
this scaffold is disrupted, ERK1/2 activation can still occur via plasma membrane 
activation, however parasite mediated ERK1/2 phosphorylation is completely 
ablated.  It has been shown that protozoans are able to interact with microtubules 
and dynein, such as Trypanasoma cruzi [16].  T. cruzi and L. amazonensis, are 
members of the kinetoplastididae and share certain similarities.  T. cruzi has 
been shown to engage host cellular pathways, MTs and specifically the kinesin 
motor protein for export from the cell, which is responsible for T. cruzi vacuole 
biogenesis [16].   
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Protozoans are known for their ability to remodel the cellular architecture 
to benefit their chances of survival, and many do this by accessing the 
perinuclear region of the host cell.  This region is important for various reasons, 
the proximity to the nucleus also enables the pathogen to be in proximity to the 
endoplasmic reticulum and the Golgi, both which are excellent sites for access to 
nutrients provided by the host.  Because L. amazonensis would benefit greatly 
from this location, and could potentially be using this site to promote anti-TH1 
substrates becoming activated via induction of ERK1/2 phosphorylation, we 
sought to analyze whether the parasite is using motor proteins, specifically 
dynein to promote perinuclear localization of the PV and direct the signaling 
responsible for a lack of a strong TH1 response that this parasite elicits.  
Here, we use two inhibitors that have been previously used in other 
systems to show pathogen hijacking of host motor proteins and cytoskeleton 
structure.  Ciliobrevin, a dynein inhibitor and Colchicine a MT inhibitor were both 
used to determine whether partially inhibiting dynein and MTs prevented L. 
amazonensis from accessing the perinuclear region.  We also show that this is 
specific to L. amazonensis as the IC that is phosphorylated post-infection does 
not occur with L. major.  We propose that the parasite is using ERK1/2 to 
increase dynein IC phosphorylation, to promote the PV it inhabits close to the 
nucleus to potentially prevent TH1 polarization by activating anti-TH1 substrates.  
We found that cytosolic phospholipase A2 (cPLA2) is one of these substrates 
activated by MAPK. cPLA2 has been previously shown to interact with TH1 
response development. 
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Materials and Methods 
Cell Lines 
J774s and RAW 274.7 (kind gift of Lee-Ann Allen, University of Iowa), 
passage 15 were used. Bone marrow-derived macrophages (BMMs) and bone 
marrow derived dendritic cells (BMDC) were also used, obtained from 12-week 
old male C57BL/6 mice.  Cells were stimulated with L929 cell-conditioned media 
for 10 days and then harvested as described previously. Cells were then plated 
onto 24-well culture plates to be analyzed via immunofluorescence, or plated for 
immunoblotting.  Cells were grown at 37oC with 5%CO2. 
 
Parasite culture and infection 
L. amazonensis strain (MHOM/BR/00/LTB0016) and L. major 
(MHOM/IL/80/Friedlin) were used and cultured with Graces media as described 
elsewhere [17-19] in an incubator at 28oC.  For in vitro experiments infectious 
parasites that were at the stationary phase were used.  RAW 264.7 murine 
macrophages, and BMMs were infected with a 3:1 parasite to cell ratio and 
incubated for indicated times at 34oC with 5%CO2. 
 
Western Blot analysis 
Cell lysates were obtained by re-suspending 1.5 x 106 BMM or RAW 
264.7 cells in 1x of 400µl of cell lysis buffer (Cell Signaling Technologies, 
Beverly, MA).  A protease and phosphatase cocktail inhibitor (Thermo Scientific, 
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Rockford, IL) was added immediately prior to use.  Samples were incubated on 
ice for 15 min and centrifuged at 16,000 x g for 10 min at 4oC.  Pellet was 
discarded, and supernatants collected, and stored at -80oC.  Protein 
concentration was determined via BCA protein assay (Pierce, Rockford, IL) and 
samples normalized to 1mg/ml.  Samples were denatured with 4x loading buffer 
for 5 min in boiling water.  Gel electrophoresis was performed on a 12% SDSD-
PAGE separating gel, and a 4% stacking gel. Gels were blotted onto a 
polyvinylidene fluoride membrane (PVDF), blocked with 5% bovine serum 
albumin (BSA) for 1 hour.  Antibodies specific to cPLA2, and the intermediate 
chain of dynein (a kind gift of the Pfister Lab, and provided by Andrew Catling, 
Louisiana State University) were used at a 1:1000 dilution. A specific p-PXSP 
antibody was also used.  Signals were detected via incubation with horseradish-
peroxidase (HRP)-conjugated goat anti-rabbit antibodies (1:20,000) (Jackson 
ImmunoResearch, West Grove, PA) and addition for 5 minutes of the 
SuperSignal west chemiluminescent substrate (Pierce, Rockford, IL).  Signal was 
detected on radiography film. 
 
Immunofluorescence labeling 
J774 macrophages and BMMs were plated onto 24-well plates at a 
density of 5x105 that contained coverslips and incubated at 37oC with 5%CO2.  
Cells were activated 4 hours prior to infection with LPS (100ng/ml) and IFN- 
(5ng/ml).  Cells were treated with U0126 (Cell Signaling, Beverly, MA) (25µm/ml) 
when indicated two hours prior to infection.  Macrophages were infected with 
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parasites a 3:1 parasite to cell ratio.  Parasites were labeled with CFSE or Cell 
Tracker Orange prior to infection.  At 2 and 4 hour time points, cells were 
harvested and fixed with 4% paraformaldehyde for 15 minutes, and subsequently 
washed three times with phosphate buffered saline (PBS). Coverslips were then 
washed with PBS and mounted with DAPI anti-gold Fade stain per the 
manufacturer’s instructions (Life Technologies, Grand Island, NY).  Analysis was 
carried out using a Zeiss LSM510 confocal (Carl Zeiss Microscopy, Jena, 
Germany, provided through NIHSI grant 1 S10 RR12916-01). 
Results 
Dynein intermediate chain is phosphorylated as a result of L. amazonensis 
infection 
 Salmonella, has recently been shown to also make use of the MP1/p14 
scaffold, the same system being used by L. amazonensis. ERK1/2 is also 
implicated in Salmonella infection, as the IC of dynein was phosphorylated via 
ERK1/2 [20], which was dependent on the MP1 scaffold.  Since, L. amazonensis 
is also using the MP1 scaffold, and induces p-ERK1/2, it is probable that the 
intermediate chain of dynein is being phosphorylated via parasite-mediated p-
ERK1/2.   
 Bone marrow derived dendritic cells (BMDCs) were utilized to test for 
phosphorylation of the IC of dynein due to L. amazonensis infection.  The use of 
the MEK inhibitor, PD98059 was also used to determine whether parasite 
induced ERK1/2 was involved in this pathway.  BMDCs were infected for 2, 4 and 
6 hours upon which point lysates were collected and prepared for immunoblots.  
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As indicated in Figure 1, total-intermediate chain protein was detected in all of 
the samples, regardless of whether the cells were treated with or without 
PD98059.  An uninfected sample showed minimal phosphorylation of the 
intermediate chain with or without PD98059 treatment.  While phosphorylation of 
the intermediate chain was observed at 2, 4, and 6 hours, the use of the 
PD98059 inhibitor caused a progressive decrease in p-dynein IC 
phosphorylation, until at 6 hours signal was almost completely ablated.  These 
results indicate that the parasite is mediating p-IC of dynein through p-ERK1/2.  
Previously, we have shown that ERK1/2 phosphorylation, mediated by the 
parasite was capable of decreasing CD40 levels in DCs, leading to their inability 
to properly mature, and therefore not being able to properly present antigen [21].  
The main difference between L. amazonensis and L. major, is that the former 
induces p-ERK1/2 upon infection.  Inhibition of ERK1/2 leads to enhanced 
parasite killing [22].  Therefore, because we know that CD40 is transcribed in the 
nucleus, and that inhibition of parasite induced ERK1/2 activation can restore 
CD40, we have speculated that ERK1/2 must be further activating downstream 
substrates.  These substrates, when in close proximity to the nucleus, can 
possibly induce factors that lean away from a strong TH1 response.  It is well 
known that the location from where signaling originates, affects signal strength.  
A well-known example is the EGF receptor.  Signals that originate at the 
endosomal membrane from internalized EGF receptors have extremely different 
outcomes compared to signals that originate from EGF receptors located at the 
plasma membrane [23]. This difference in outcome is solely due to signals 
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originating from different spatial locations.  The fact that the parasite is able to 
induce dynein IC chain phosphorylation points towards a mechanism wherein the 
parasite is hijacking dynein.  Dynein transports cargo in a retrograde fashion 
towards the inner minus-end of microtubules, and based on previous data 
showing that location of the signal can lead to weak cross-talk [23], location of 
the PV could affect parasite mediated signaling strength.  It is probable that a 
perinuclear location of the PV, would allow for strong signaling to occur on 
substrates that may possibly counter against TH1 polarization. 
 
J774 macrophages treated with colchicine are not more or less prone to infection 
than untreated cells 
 J774 murine macrophages were analyzed to detect whether or not 
interfering with tubulin could potentially prevent infection.  The parasite could 
potentially be using host tubulin to travel to a perinuclear region.  Cells treated 
with tubulin inhibitor were not disrupted in their ability to be infected.  Figure 2 is 
a representative panel of J774s that were labeled for tubulin (AF488), nuclei 
(DAPI) and parasites (CTO).  2A indicates the cellular distribution and structure 
of tubulin in non-infected cells. 2B represents a single macrophage infected with 
three visible parasites, 4 hours post infection.  As indicated by the image, 
parasites (red) are in the perinuclear region and in close proximity to the host cell 
nucleus.  2C is a single macrophage infected with L. amazonensis, treated with 
colchicine.  Parasite infection was not disrupted in either inhibitor treated or non-
treated cells.  The main difference is colchicine tubulin inhibition (not depletion) 
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places parasites at 4 hours post infection in the cell periphery, indicating it is 
using dynein and MTs to become perinuclear.  Figure 2B is not treated with 
colchicine, therefore what appears to be cytoskeleton disruption seen in 2B and 
2C compared to control (2A) is probably due to parasite infection. It is 
possible that the parasite causes cytoskeleton remodeling upon infection of the 
cell, a mechanism other pathogens have been shown to do immediately upon 
infection [7]. 
 
Leishmania amazonensis location is affected by the use of colchicine, a tubulin 
inhibitor 
 To determine the effect of colchicine upon parasite localization, we 
infected J774s and treated with colchicine for 30minutes, and 2.5 hours.  Mock 
cells were treated with DMSO, the solvent used for the colchicine inhibitor.  
Distance was measured via µm units by confocal microscopy, measuring from 
the edge of the nucleus to the edge of the parasite.  Macrophages that were not 
treated were on average 2µm from the nucleus in 900 counted cells (three 
coverslips, with 300 cells counted per coverslip) (Figure 3).  Cells treated with 
colchicine had a significant difference in both time points in their distance 
measured from the nucleus.  In fact, there was almost a three-fold difference 
between colchicine treated cells and mock cells.  Of note, L. amazonensis 
appears to travel towards the nuclear region regardless of colchicine inhibition.  
The distance measured at 2.5 hours showed parasites were closer to the 
perinuclear region compared to 30 min post colchicine treatment.  Thus, 
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indicating that there might be other inefficient methods used to compensate the 
inhibition of colchicine. 
 
Dynein intermediate chain phosphorylation is parasite mediated ERK1/2 specific 
 RAW 264.7 cells were infected with L. amazonensis.  Cells were either 
treated with or without U0126, a MEK inhibitor.  Figure 4 shows an increase in 
phosphorylation of the intermediate chain of dynein.  Inhibition of ERK1/2 via the 
use of U0126 greatly inhibits this phosphorylation.  These results indicate that the 
IC of dynein is being phosphorylated in a parasite mediated ERK1/2 manner.  
This is specific to the presence of ERK1/2 induced by the parasite. Once ERK1/2 
is inhibited we see a decrease in the phosphorylation of IC.  This implies that the 
parasite, via mediating p-ERK1/2, is then potentially phosphorylating the IC of 
dynein, a result that is dampened upon ERK1/2 inhibition. 
 
Leishmania amazonensis is responsible for downstream substrate 
phosphorylation 
Previous data showing a decrease in CD40 mediated by parasite induced 
p-ERK1/2 by L. amazonensis indicated to us that the parasite is using its 
perinuclear location, and p-ERK1/2 to possibly promote anti TH1 responses.   
Bone marrow derived dendritic cells were infected with L. amazonensis for 2 and 
4 hours.  Again, cells were either treated with or without U0126 as indicated in 
the blot.  The blot indicated a strong presence of a protein in the ~100kDa range.   
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This phospho-PXSP specific target was being phosphorylated at 2 and 4 
hours upon infection with the parasite, which was almost completely ablated 
(indicated by the arrow) upon treatment with U0126 inhibitor.  This indicates that 
this substrate is being specifically phosphorylated due to the presence of the 
parasite and ERK1/2 induction. PXS/TP is a consensus sequence that is only 
phosphorylated via MAPKs. P indicates proline, X is any amino acid, S – serine, 
T- Threonine, and P- Proline. 
 
cPLA2 is phosphorylated during infection by Leishmania amazonensis. 
L. amazonensis phosphorylated a substrate as indicated in Figure 5. These 
bands were sequenced, and through the use of mass spectrometry, it was 
elucidated that this corresponded to the cPLA2 protein.  A blot was then run to 
confirm this on J774 macrophages lysates infected with L. amazonensis with a 
cPLA2 antibody (Figure 6).  Immunoprecipitation was done, which showed 
strong induction of cPLA2 in time points with non-inhibitor treated cells.  U0126 
treated cells had a reduced phosphorylation state of this protein, which was 
confirmed to be cPLA2, a protein that amongst its many functions, is involved in 
the production of reactive oxygen species.  cPLA2 is one of the substrates that is 
becoming phosphorylated via parasite-mediated p-ERK1/2 as this 
phosphorylation was ablated upon p-ERK1/2 inhibition post-infection with L. 
amazonensis.   
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Discussion 
 It is well established that motor proteins are essential for cellular functions 
that involve transport of proteins and organelles that are required for the cell to 
properly function.  This type of transport is inherent to all cell types, and is 
therefore a system that pathogens have also had time to exploit for their own 
benefit.  Leishmania amazonensis is known to benefit from using ERK1/2 to 
activate downstream substrates, presumably ones located in the nucleus that 
would enhance a TH2 response and dampen any factors that promote a strong 
TH1 response.  Location therefore is extremely important for the parasite, and the 
use of motor proteins, specifically dynein, might be used as a means to reach the 
perinuclear region.  A number of studies have shown pathogens including 
bacteria, parasites, and viruses have been hijacking motor proteins through a 
variety of mechanisms.  We know various viruses facilitate their entry into the 
host cells by the use of cytoplasmic dynein, which aids in their movement 
towards the MTOC region in the early stages of infection [8].  In fact many of the 
mechanisms as to how this occurs have been elucidated in detail. As the 
previously mentioned, pathogens directly interact with host motor proteins, and 
HSV1 can recruit dynein to facilitate transport. Therefore, the postulation that L. 
amazonensis might be using this same mechanism is not without precedence in 
the array of mechanisms used by other pathogens to access the host cell.  In 
fact, adenovirus has been found to interact with the IC chain of dynein and recruit 
dynein. Evidence indicated that only viruses exposed to an endocytic 
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compartment with low pH were able to recruit dynein.  T. cruzi used the host 
motor protein kinesin in an anterograde fashion to exit the cell.   
 L. amazonensis could possibly benefit greatly from being positioned in a 
perinuclear location of the host cell.  Not only can it use host nutrients that are in 
the surrounding location from the Golgi and endoplasmic reticulum, but also 
nucleus proximity might be affecting its signaling strength to downstream 
substrates.  Because ERK1/2 plays such a major role in promoting L. 
amazonensis infection, we sought to establish whether the activation of ERK1/2 
is promoting parasite perinuclear localization through the use of the host 
cytoskeleton, or dynein, the key retrograde motor protein.   
 We have been able to establish in this study that inhibition of dynein, or 
tubulin leads to a decrease in p-ERK1/2 post parasite infection (data not shown).  
While at first this might seem circular, it’s important to remember that a cell is 
usually infected by multiple Leishmania parasites at a time. It is possible that 
upon infection with one-parasite, macrophages becomes more permissive to 
infection with other parasites.  Once the first parasite accesses the perinuclear 
region, it can enhance the phosphorylation of the intermediate chain of dynein, 
which in essence allows the motor protein to associate with dynactin.  This 
complex is needed for cargo transport within the cell.  Priming various of these 
motor proteins at different sites in the plasma membrane, would make any 
incoming parasites prior to the initial breach more accessible to use of the motor 
proteins.  However, we are not implying that entry is dynein dependent.  Rather 
the parasite likely enters the host cells and establishes itself within the PV, is 
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then exposed to a low pH, and can then recruit dynein and motor proteins, which 
some viruses have been shown to do [9, 24].  From within the PV the parasite is 
now able to upregulate ERK1/2 through the endosomal scaffold, which has been 
shown before.  PKC has been previously shown to phosphorylate the IC of 
dynein prior to cell migration [25] and has also been shown to decrease the 
phosphorylation of the p47phox subunit [26] upon infection with Leishmania 
donovani.  Therefore, other Leishmania spp. are also disrupting the formation of 
the NADPH complex and evading the effects of ROS. Because cPLA2 has been 
identified as a potential target of parasite induced ERK1/2, future studies should 
investigate how phosphorylation of this protein might be beneficial for the 
parasite.  cPLA2 has a variety of functions, and these include ROS formation, as 
well as elevated levels of cPLA2 leading to inflammation and tissue damage.   
Therefore, based on the clinical signs presented with individuals infected 
with chronic L. amazonensis, it would imply that the parasite might need to 
delicately balance between the cutaneous lesions we do observe as a result of 
infection, as well as preventing ROS production at levels that could induce killing.  
ROS are used cell functions that are not damaging at minimal levels.  Therefore, 
further studies would need to investigate what targets cPLA2 phosphorylation is 
having when induced via the parasite.  This study concludes however, that 
ERK1/2 can be elucidated via the methods used herein, opening the door to 
determine further substrates that might be induced.  This would clarify the lack of 
a strong TH1 response that we see in L. amazonensis infection, as well as 
provide us with specific targets for immunomodulation.  
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Figure 1.  Dynein intermediate chain was phosphorylated at S81 after L. 
amazonensis infection in Bone Marrow Derived Macrophages in an ERK 
dependent manner. 
Bone marrow derived macrophages were treated with and without PD98059, 
which inhibits MEK.  Lysates were blotted for total dynein intermediate chain, and 
for the phosphorylated dynein intermediate chain. 
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Figure 2.  Colchicine effect on microtubules does not prevent parasite 
infection, affects parasite location 
J774 macrophages were infected with L. amazonensis for four hours.  Cells were 
either treated without colchicine. Parasites were labeled with Cell Tracker 
Orange, and tubulin with AF488, nuclei with DAPI.  A.) L. amazonensis parasites 
were able to successfully localize to the perinuclear region of the macrophage. 
B.) Upon use of colchicine, parasites were restricted mainly to the periphery of 
the cellular macrophage membrane. Lower panel represents more cells with no 
treatment (left) and inhibitor treated (right). 
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Figure 3.   Colchicine alters the ability of L. amazonensis to localize to the 
perinuclear region. 
J774 macrophages were infected with L. amazonensis for four hours.  Cells were 
either treated without colchicine post infection.  Colchicine treated cells had 
parasites located further from the nucleus than mock treated cells at both 30min 
and 2.5hrs post-inhibitor treatment. 
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Figure 4. Dynein IC is phosphorylated in RAW 264.7 macrophages infected 
with Leishmania amazonensis, the use of the U0126 inhibitor shows this is 
ERK1/2 dependent. 
RAW 264.7 macrophages were infected with L. amazonensis. Cells were 
infected for 2 and 4 hours, with and without U1026 inhibitor. The second lane of 
each time point are pretreated with U0126.  
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Figure 5.  L. amazonensis is responsible for downstream substrate 
phosphorylation. 
Bone marrow derived dendritic cells were infected with L. amazonensis for 2 or 4 
hours as indicated in the blot.  Cells were treated with and without U0126, a 
specific MEK inhibitor.  Lysates were collected and used for immunoblotting.  As 
the blot shows, there was a strong presence of a ~100kDa protein seen 
especially activated at 2 and 4 hours post infection with the parasite.  Upon use 
of the U0126 inhibitor, the previously phosphorylated protein with ERK 
consensus sequences was almost completely ablated. 
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Figure 6.  cPLA2 is phosphorylated during infection by Leishmania 
amazonensis. 
J774 macrophages were infected with L. amazonensis for 2 and 4 hours.  
Motif IP PLA2-antiphospho PXSP IPs blotted with PLA2 antibody.  First two lanes 
are indicative of infection without inhibitor.  Last two lanes are infected with L. 
amazonensis and cells were pre-treated with U0126. 
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CHAPTER 5: General Conclusions 
Summary 
 Previous work in Leishmania amazonensis in regards to the MAPK  
pathway, specifically ERK1/2 has built upon and focused on the fact that L.  
amazonensis leads to chronic infection, unlike Leishmania major which the host  
is able to clear.  However, previous to this work very little was known regarding  
the mechanisms by which L. amazonensis- mediated ERK activation would alter 
the host macrophage response. Throughout these chapters, we have learned  
that ERK1/2 is not solely a bystander protein, but rather we are only just  
beginning to understand just how important and how intricately related it is to  
parasites promotion of infection and survival.   
 This work begins with establishing the site of parasite induced ERK1/2 
phosphorylation at the endosome.  Previously, it had been shown that L. 
amazonensis strongly induced ERK1/2 activation in macrophages post-infection.  
Inhibition of ERK1/2 led to enhanced parasite killing, and while this was 
provocative, it was a generalized view of what was occurring and lacked in 
providing temporal and spatial information of where this was taking place.  
Inhibiting ERK1/2 in vitro was easily done, there are many commercially available 
inhibitors. Inhibition proved to be beneficial in terms of a cell host response, with 
increased parasite killing.  However, a pan-ERK1/2 inhibitor would be fruitless as 
an anti-leishmania drug, as ERK1/2 is essential to the cell, and therefore host 
survival.  A key point that was made in the first part of this work, was that 
disruption of a scaffolding complex that is specific only to endosomes would also 
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disrupt the ability of the parasite to induce ERK1/2 activation.  Through the use of 
a mutant fibroblast cell line, in which MP1 had two mutations at two key amino 
acid sites (LS), this scaffold was no longer able to properly bind to the proline rich 
region of MEK1/2.  With this knowledge in hand, we set out to test whether 
infecting these fibroblasts with L. amazonensis would lead to the typical ERK1/2 
increase in phosphorylation normally seen in infected macrophages – or if 
disrupting the ability of the scaffold to properly form at the endosome and bind 
the corresponding proteins would also impact the parasite.  Consistent with our 
hypothesis, disruption of the complex led to complete ablation of parasite-
induced p-ERK1/2.  Because these results could possibly be attributed to having 
disrupted a key cellular pathway while performing site directed mutagenesis we 
sought to ensure p-ERK could still be induced in the mutant cells.  We decided to 
stimulate the cells with epidermal growth factor (EGF).  At all analyzed time 
points, the cell was able to strongly induce ERK1/2 phosphorylation in both 
wildtype and LS cells in response to EGF, but the mutants were not able to 
induce p-ERK in response to parasite infection while the wildtype cells did.  This 
indicated to us that ERK1/2 activation at the plasma membrane was perfectly 
capable of being phosphorylated and induced – it was only the disruption at the 
endosomal scaffold, a location where the parasite resides, that was prevented 
from p-ERK1/2 production.  These results were extremely promising, because it 
provided proof that the parasite was indeed mediating ERK1/2 phosphorylation, 
but more importantly that this activation was occurring from within the same 
endosome the parasite inhabits.  This data confirmed previously unknown 
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information regarding the location from which the parasite was inducing the 
ERK1/2 seen.  The parasite is using part of the cellular mechanism – a 
scaffolding complex -, to prevent its own demise.  While fibroblasts are not 
primary targets of Leishmania, they are secondary targets, and a place where 
parasites will live on silently even after host resolution.  Therefore, this provides a 
great model system that shows the importance of host scaffolding proteins in 
providing targeted parasite signaling from within the PV.  Location specific 
signaling is the take home message of the first part of the story.  Previously, it 
had been shown that CD40 is inhibited upon L. amazonensis infection.  CD40 is 
essential for dendritic cell activation.  Without proper activation, there cannot be 
proper antigen activation, leading to a failed and weak TH1 response, leading to 
chronic disease.  IL-12p40 is also not becoming activated due to parasite 
mediated ERK1/2 phosphorylation.  IL-12 along with IFN-γ is an essential 
cytokine needed for a strong TH1 response.  The use of the scaffold provides the 
parasite with specificity upon which to act upon further downstream substrates. 
 Building upon our previous chapter, we decided to investigate the role L. 
amazonensis might have in ROS production, or lack thereof.  Previously, it had 
been shown that inhibiting ERK1/2 via the use of the non-specific MEK inhibitor, 
PD98059, led to enhanced intracellular parasite killing.  Using a superoxide 
scavenger, this enhanced killing was ablated, indicating that ERK1/2 was 
possibly being used by the parasite to somehow prevent superoxide production.  
However, mechanisms as to how this was occurring were speculative at best, as 
no direct link between ERK1/2 inhibition and superoxide production was 
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demonstrated.  This data however, did set the foundation on which to build our 
second hypothesis, which is that L. amazonensis is phosphorylating ERK1/2 not 
only for CD40 dampening, but also to interfere with the ability of the macrophage 
to properly activate all of the cytosolic and membrane subunits from properly 
coming together.  Thereby, preventing the NADPH complex from successfully 
mounting a proper respiratory burst that could lead to parasite killing.  To 
elucidate whether L. amazonensis infection and superoxide ablation was indeed 
due to parasite mediated p-ERK1/2 we analyzed the NADPH subunits.  As 
expected, we confirmed that NADPH subunits properly assemble in L. major 
infected RAW 264.7 and bone marrow derived macrophages. L. amazonensis 
however did not have any subunit co-localization in the majority of observed 
cells.  This was expected since a strong respiratory burst capable of killing the 
parasite is not observed with L. amazonensis infection.  The vacuoles present in 
L. amazonensis infected cells failed to show association of cytosolic and 
membrane subunits.   
When inhibiting ERK1/2 with the U0126 inhibitor, which directly inhibits the 
upstream kinase MEK1/2, we noticed a reversal of results observed in non-
treated cells.  U0126 inhibition of L. amazonensis infected cells resulted in a 
restoration of superoxide production, indicating that ERK1/2 phosphorylation 
induced by the parasite is key in preventing this host defense mechanism from 
occurring during infection.  Because Akt is able to phosphorylate the cytosolic 
subunit p47phox, we speculated that in the process that leads to superoxide 
production, Akt was somehow being prevented from accomplishing this task.  We 
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do not believe that ERK1/2 is necessarily preventing Akt phosphorylation 
completely to accomplish this.  On the contrary, it is quite possible that Akt is still 
becoming phosphorylated via engagement of the PI3K pathway, or as is needed 
for normal cell function and homeostasis.  However, through a 
pathway/mechanism that is still unknown Akt might be dephosphorylated before 
it can activate p47phox.  After Akt phosphorylation, Akt has to translocate to 
p47phox, and associate with the cytosolic subunit to phosphorylate the sites on 
p47phox required for activation.  It is possible that ERK1/2 is preventing this 
interaction at this step, and not necessarily the prevention of p-Akt altogether.  It 
is possible Akt is acting through a downstream substrate that can potentially be 
activating a phosphatase similar to SHP.  These enzymes remove phosphate 
groups from phosphorylated proteins, therefore preventing activation.  We know 
this occurs in other pathways of the cell as well. SHPs are active during TCR 
activation by actively removing phosphate groups to inhibit activation, acting as a 
regulator of this system.  Therefore the idea that Akt is becoming phosphorylated 
and is either being dephosphorylated by SHP like phosphatases, or that p47phox 
is being regulated by a phosphatase itself is probable.  Inhibiting Akt during L. 
major activation (Chapter 3) led to a loss of superoxide formation, which directly 
implicates Akt in the superoxide production pathway.  Now, the task remains to 
elucidate specifically which substrate mediated by parasite induced ERK1/2 is 
acting upon either Akt or p47phox to prevent NADPH formation.   
 Finally, our third contributing segment to this story lies on motor proteins 
interaction with L. amazonensis.  Motor proteins have long been known to be 
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essential for cellular function in terms of cargo transport and to enhance signaling 
within the cell.  Yet, this mechanism has also proven to be essential for 
pathogenic infection strategies. Pathogens such as bacteria, viruses and 
parasites have all been reported to use host motor proteins to further ensure 
infection. In this third chapter we sought to answer whether this is the case for L. 
amazonensis.  From previous studies, we know that the parasite downregulates 
CD40, leading to an improper TH1 response.  For the parasite to have strength in 
signaling, it is likely that it uses mechanisms to locate itself in a perinuclear 
fashion in the infected host cell.  Being in this position would be beneficial for the 
parasite because as previously discussed, location affects signal strength.  Not 
only would it benefit from access to nutrients from the nearby endoplasmic 
reticulum and Golgi, but it would also be able to signal more strongly to nuclear 
substrates that would enhance its survival.  We show in this part of the thesis, 
that the parasite might be mediating the phosphorylation of the intermediate 
chain of dynein.  The phosphorylation of the intermediate chain is essential for 
cargo transport.  By doing so, the parasite might be ‘hijacking’ a system already 
in place in the host cell.  Using this motor protein that travels towards the minus 
end of microtubules instead of kinesin, would ensure its perinuclear location.  We 
then demonstrated that upon inhibition of dynein or MTs, the location of the 
parasite was severely affected.  Infection of cells treated with or without the 
inhibitors was not affected.  Cells that were treated with inhibitor lead to parasites 
that were localized at the cell periphery.  Cells that did not have inhibitor 
treatments showed parasites in perinuclear regions, indicating the parasites are 
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indeed using dynein and MTs to become perinuclear.  Furthermore, 
phosphorylation of the dynein intermediate chain was directly correlated to 
parasite mediated p-ERK1/2.  Upon ERK1/2 inhibition in infected cells, the 
phosphorylation of the dynein IC was almost completely ablated.  Therefore, 
providing further evidence that the parasite is inducing this IC phosphorylation 
seen via ERK1/2.  Finally, we elucidated a specific protein that is being 
phosphorylated via parasite induced ERK1/2, cPLA2, that will be further 
discussed below.  Because ERK1/2 is at the center of all these mechanisms that 
the parasite is exploiting, a model is provided (Figure 1) that shows how all three 
chapters are connected.  ERK1/2 phosphorylation mediated by the parasite is 
why we believe the NADPH complex cannot properly form, it leads to the 
phosphorylation of the dynein IC to promote its transport to the perinuclear 
region, and finally it gives it specificity via the MP1-MEK scaffolding complex.  
Below, the main summary of each chapter is explained. 
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Discussion 
 
Scaffolding complex 
ERK1/2 is essential to cell function and survival.  However, based on the 
data, it seems that it is essential for parasite survival as well.  The parasite is 
known to live within a PV, the location from which it is mediating the manipulation 
of host signaling pathways.  Boggiatto et al. [1] previously showed that the 
parasite is able to promote its survival by using ERK1/2 to decrease CD40, and 
IL-12 production.  These two factors are essential for proper parasite resolution.  
Inhibition of ERK1/2 led to CD40 restoration, indicating the parasite was actively 
dampening this marker needed for dendritic cell maturation.  Through the use of 
a scaffolding complex, it was then proven that the parasite is mediating this 
signaling through the use of the MP1 scaffold complex [2].  We elucidated this by 
using fibroblasts as a model system, wherein the scaffolding complex was not 
able to properly assemble.  An amino acid change in MEK of these mutant 
fibroblasts led to prevention of MP1 from binding to the proline rich region on 
MEK.  The results observed showed that ERK1/2 phosphorylation was 
completely abolished as a result of this inhibition.  ERK1/2 activated at the 
plasma membrane however was induced in both wildtype and mutants.  This 
indicated that the parasite is using this scaffold to promote signaling to substrates 
that lead to its survival.  Without the scaffold in place, the parasite is not able to 
induce ERK1/2 phosphorylation.  This is highly important, because for the first 
time in L. amazonensis studies, and in the Leishmania spp. field in general, this 
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had never been shown.  The fact that the parasite is using a very specific 
scaffolding protein, MP1, which is found only at the endosome has many 
implications.  pan-ERK1/2 inhibition is not possible even though we know that 
inhibition of L. amazonensis induced ERK1/2 leads to parasite killing, especially 
when acting together with nitric oxide [3].  It is possible however to target specific 
proteins to ameliorate the chronic disease caused by L. amazonensis.  Finding 
specific targets allows us to more properly inhibit proteins without affecting cell 
function and develop drug therapies against the parasite. 
 
 
ROS evasion through the use of Akt 
Mukbel et. al [3] has shown that superoxide production along with nitric 
oxide is required for parasite killing.  Neither system alone has as an enhanced 
killing effect on L. amazonensis as when acting synergistically.  Superoxide 
formation is known to be essential for host defenses against pathogens [4] and a 
defect of any subunit can leads to a system that is severely immune-
compromised, such as what we see in CGD [5].  Yet, L. amazonensis has found 
a mechanism to evade this system by employing the activation of another central 
host protein, the MAPK ERK1/2.  We hypothesized that Akt might be involved in 
this pathway, as it has been shown to phosphorylate p47phox [6, 7].  p47phox 
has been shown to be dampened to prevent superoxide production in another 
species, L. donovani [8].  Therefore, the suppression of superoxide by other 
Leishmania spp. is not without precedence.  However, the mechanism does 
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differ, as L. amazonensis depends heavily upon ERK1/2 phosphorylation for its 
survival.  In both RAW 264.7 macrophages and primary bone marrow 
macrophages we found a lack of NADPH subunit co-localization when infected 
with L. amazonensis.  As such, inhibiting ERK1/2 with the highly specific U0126 
inhibitor reversed this superoxide block.  Moreover, the superoxide levels and 
quantity of cells infected with L. amazonensis and treated with U0126 were 
nearly as equal as that detected in L. major infected parasites.  L. major causes 
superoxide production in macrophages upon infection, which can aid in killing the 
parasite.   
Therefore to see this occurring at the same degree implicates a strong 
role for p-ERK1/2 mediate by the parasite in modulating the ROS response in its 
favor.  Akt was then inhibited in macrophages infected with L. major.  As a result, 
almost complete ablation of ROS was detected.  This provides more evidence 
that Akt is likely to be involved in initiating the cascade that leads to translocation 
of the cytosolic subunits to the membrane and associate with the 
flavocytochrome.  Subunit co-localization was also analyzed, as this indicates 
proper NADPH complex formation needed for the respiratory burst.  Without 
U0126 inhibitor, L. amazonensis cells failed to produce significant levels of ROS 
and any visible cytosolic subunit co-localization with the membrane subunits.  
Cells with U0126 inhibitor infected with L. amazonensis however proved to 
restore their ability to translocate cytosolic subunits (p47phox, p40phox, and 
p67phox) to the membrane (gp91phox and p22phox).  This implicated parasite 
induced ERK1/2 again in preventing and actively disrupting the formation of the 
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NADPH complex.  p-p40 was also increased in cells that were treated with 
U0126 and infected with L. amazonensis (data not shown) indicating that the 
complex is properly assembling.  Akt appears to be used in mediating this lack of 
superoxide response observed in L. amazonensis infection.  Therefore, Akt, 
serves as a new host protein that is being exploited by the parasite for its own 
survival.  Elucidating exactly how this is occurring is vital for any 
immunotherapies or modulation that can occur as a result of this information. 
 
Importance of parasite perinuclear localization  
 Finally motor proteins were pinpointed as one of the possible mechanisms 
L. amazonensis is using to access the perinuclear region of the cell, mediated by 
ERK1/2, induced by the parasite.  Motor proteins and the cytoskeleton as 
previously stated have a long proven record in interacting with pathogens and 
facilitating their entry or exit; such as: Salmonella, T. cruzi, HSV, etc. [9-12].  In 
fact, HSV has been shown to interact with the intermediate chain of dynein, 
something we postulate that L. amazonensis might be doing.  We show in this 
chapter that L. amazonensis is able to phosphorylate the intermediate chain of 
dynein.  Specifically, it does this in an ERK1/2 dependent manner.  When 
ERK1/2 is inhibited with U0126 in L. amazonensis infected cells, the 
phosphorylation of the IC of dynein is greatly dampened.  Furthermore, we 
characterize that inhibiting dynein, or microtubules, does not prevent cells from 
becoming infected, but it does alter the parasites ability to localize to a 
perinuclear region.   
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The perinuclear region is important because it would provide the parasite 
with nutrients, as well as proximity to increase signal strength to further 
downstream nuclear substrates.  These substrates might be linked to anti-TH1 
effects that leads to the weak TH1 response observed in L. amazonensis 
infection.  Finally, we characterize one of many substrates that the parasite is 
acting upon via ERK1/2.  Through mass spectrometry, it was characterized that 
cPLA2 is being phosphorylated when the cell is infected with the parasite, but the 
effect is gone when ERK1/2 inhibitor is used, implicating the parasite as the 
reason for this phosphorylation.  cPLA2 has various functions, amongst being 
part of a cascade that leads to ROS.  Because elevated levels of cPLA2 cause 
tissue damage and inflammation, it is possible this is one of the reasons we see 
cutaneous lesions with L. amazonensis.  It would be interesting to note how the 
parasite balances cPLA2 activation to not produce superoxide to levels that 
would promote parasite killing. 
 
Recommendation for future studies 
Finally, further studies that would be recommended to properly assess 
many of the advances we have made in this field would include the following.  
Because there already exists a murine fibroblast that we have previously used as 
a model that lacks the ability to properly bind MEK with MP1, this can be used to 
elucidate that the lack of ROS seen in L. amazonensis is indeed due to ERK1/2.  
Because we know that the MP1 scaffold is specific and needed for parasite 
mediated ERK1/2, disruption of this scaffold should lead to production of 
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superoxide.  Whether this superoxide leads to a decrease in parasite killing, 
should also be assessed.  Although, this would then have to be repeated in 
primary phagocytic cells, such as bone marrow derived macrophages and 
dendritic cells, because fibroblasts are not a primary initial target of infection.  
Therefore, while providing essential initial information, it could then be repeated 
in primary cells.  Because currently we do not have a model where the 
scaffolding is compromised in phagocytic cells, we could potentially use shRNA 
to deplete MP1 in these cells, and therefore see whether the MP1-MEK complex 
is essential for the prevention of ROS production.  This scaffold complex can also 
be used to analyze whether the phosphorylation of the IC chain of dynein and 
perinuclear localization requires this complex as well.  To determine whether the 
parasite is actively recruiting dynein as some pathogens do, an 
immunofluorescence experiment could be done.  Dynein would have to be 
labeled with a specific fluor, and the parasite can be labeled with CTO or CFSE.  
Infected cells treated with an inhibitor of ERK1/2 and those treated without 
should be used.  Co-localization of the parasite and the intermediate chain would 
indicate the parasite is recruiting dynein to transport across the cell.  If this is 
mediated by ERK1/2 as we postulate, inhibiting this MAPK would lead to a lack 
of p-dynein IC and parasite co-localization.  Blocking the IC chain of dynein itself 
could also be a mechanism to prove whether or not the IC of dynein is essential 
to parasite perinuclear localization.  This could be achieved by changing one of 
the sites upon which dynein is phosphorylated on.  Because the results we see in 
parasite localization to the perinuclear region happen quite rapidly, it would also 
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be beneficial to analyze this in real-time movement and compare inhibited treated 
cells, with non treated cells in terms of effect on location.  To determine if this 
effect is specific to L. amazonensis, another Leishmania spp. could be used 
during the real-time movement analysis along with the use on inhibitors.  While 
we have used ciliobrevin, which is a dynein inhibitor, we could potentially also 
prove that the results observed are in fact due to the inhibitor, and this could be 
done by using a IC-dynein knockdown.  Another interesting experiment would be 
to analyze whether ERK1/2 is able to translocate to the nucleus if the scaffold is 
disrupted, which can be done on the fibroblasts, or through shRNA on primary 
cells.   
 
Because it is known at which sites Akt phosphorylates p47phox, these 
could be mutated through an amino acid change.  This could be done on either 
Akt, so that it can no longer phosphorylate p47phox or the inverse, on p47phox 
so that it cannot be phosphorylated due to the introduced mutations.  Because 
we believe that Akt is being inhibited by ERK1/2 to prevent proper p47phox 
activation due to parasite mediate p-ERK1/2 a couple of things can be done.  
One would be to overexpress Akt.  This should theoretically override any 
suppression that Akt might be under the influence of mediated by ERK1/2.  If Akt 
is indeed responsible for p47phox activation, inducing overexpression of Akt, 
should lead to subunit co-localization in L. amazonensis infected cells.  This 
would indicate proper NADPH complex formation and link Akt to this process. 
Finally, while p47phox is essential, perhaps the other subunits are somehow 
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being impeded from correctly forming the NADPH complex.  We should be able 
to look at the interaction between Rac and p67phox in L. amazonensis infected 
cells and see whether or not this is occurring or not.  Also, further studies in 
immunofluorescence could also label ERK1/2 to see its location or co-localization 
with the NADPH subunits.  Heme has been implicated as being needed for 
proper gp91phox maturation.  Without this maturation of gp91phox, there cannot 
be proper NADPH assembly, or RB.  Leishmania spp. have been shown to 
induce heme degradation (L. pifanoi).  It would be quite interesting to see 
whether or not L. amazonensis does a similar mechanism. Because the immune 
system has various redundant proteins that will do similar functions, it is likely 
that the parasite is not just preventing superoxide via one mechanism, but 
probably through various ones.   
 
Throughout these studies, ERK1/2 has proven to be essential for the 
parasite.  While a vaccine still does not exist for this chronic disease caused by 
L. amazonensis, the findings in these chapters provide a means for 
immunotherapy.  These might not completely cure the host, but they could 
ameliorate disease effects.  Unfortunately for the host, the MAPK ERK1/2 is 
essential for cell survival, growth, differentiation, etc., yet because it is involved in 
so many pathways, it also provides the parasite with ample opportunity to 
manipulate these for its own persistence and survival 
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Model 
ERK1/2 is essential not only for the host, but for Leishmania amazonensis 
as well 
Leishmania amazonensis inhabits the PV upon cellular infection, leading to 
chronic infection in the host.  Here, we propose that it is acting in 3 different 
manners essential to its survival, with one commonality – the manipulation of 
host p-ERK1/2.  Starting from the left, we have the PV, which through parasite-
mediated p-ERK1/2 is preventing the translocation of cytosolic NADPH subunits 
(yellow) with membrane subunits (black) thereby preventing ROS production, 
presumably by inhibiting Akt.  The subunit co-localization happens in vacuoles 
around the invading pathogen.  In the middle part of the model, we have already 
proven that the parasite signals through the MP1-MEK scaffold, essential for 
parasite induced p-ERK1/2.  This event then leads to further downstream 
substrates to be elucidated, as well as the ones currently known.  Finally, to the 
right we have the PV, which through parasite-mediated p-ERK1/2 is 
phosphorylating the IC of dynein.  We believe the parasite is hijacking dynein to 
promote the ability of the PV to travel towards the perinuclear region of the host 
cell, and possibly further dampening TH1 responses.  The parasite has previously 
been shown to dampen CD40 and IL-12 through parasite-mediated p-ERK1/2. 
 
 
 
 
 143 
 
 
 
 
 
 
 
 
 
 
 
 
